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ABSTRACT
Background: In the United States, the Centers for Disease Control and Prevention (CDC) estimates that
32,000 cancers occur annually that can be directly attributable to the acquisition of the Human Papilloma
Virus (HPV). Gender specificity data posits that 21,000 of the annual cancer cases are female and the
remaining 11,000 cases occur among males. However, because the implementation and trajectory of HPV
vaccination and prevention programs have been historically aimed toward women, vaccination rates for
men remain significantly lower. The purpose of this study was to assess how gender differences in
knowledge attitude, subjective norms and perceived behavioral control about HPV and the intention to be
vaccinated among a sample of university students. The Theory of Planned Behavior was employed as the
theoretical framework for the study. Methods: a stratified proportional random sample of students
attending one university with multiple campuses was utilized to collect data. Each campus site constituted
a stratum, with two or more classes of an undergraduate level randomly selected from each campus.
Results: A total of 383 usable surveys were obtained, which is consistent with obtaining a final sample
size of 380 based on the power analysis of p≤0.05. A response rate of 84% was obtained which included
face to face and on-line administrations. Overall results indicate a significant difference in male and
female vaccination rates with females 1.945 times (1.450, 2.607) more likely to have been vaccinated
against HPV than males (received all three doses); Males were less knowledgeable than females on
specific facts about HPV and the vaccination; were less likely to be influenced by family or peers to
receive the vaccination and less likely to perceive their ability (perceived behavioral control) to obtain the
HPV vaccine as high. Best practices for health education emphasize skill acquisition however, the results
of this study suggest university health education programs need to include a strong knowledge component

along with self-efficacy skills and positive awareness messages on the benefits of receiving the HPV
vaccine.
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CHAPTER 1
INTRODUCTION

Background
The human papillomavirus (HPV) is the most common sexually transmitted infection
affecting both males and females worldwide. In the United States alone, the Centers for Disease
Control and Prevention (CDC) estimate that 44,000 cancers are directly attributable to the
acquisition of HPV occurring annually (CDC, 2019). Gender specificity data posits that 25,000
of the annual cancer cases are female with the remaining 19,000 cases occurring among males
(CDC, 2019). Empirical evidence indicates that HPV infection is the cause of nearly all cervical
cancers worldwide; however, emerging data suggests that acquiring an oral HPV infection is a
catalyst to the acquisition of a subset of oropharyngeal cancers as well (Levesque, 2011).
Oral HPV is more common in men than women (CDC, 2017), with the incidence among
males of oral HPV acquisition approximately three times higher than in females (Levesque,
2011). In the past, most incidences of throat and mouth cancers were primarily attributed to
tobacco and alcohol abuse and most of these cancers occurred among men between the ages of 60
and 80, were difficult to treat, and had high mortality rates. However, recent data suggest that
about 70% of all oropharyngeal, head and neck cancer acquisition is primarily attributable to oral
HPV infections, with HPV type 16 causing 60% of all oropharyngeal cancers (CDC, 2019).
Although the link between oral HPV infection among men and oropharyngeal cancer has
been wholly under-researched, the etiologic role of oral HPV infection in oropharynx cancer has
been recently established. In the United States, oral HPV infection is directly linked to the
majority of oropharynx cancer among men, and the total number of cases is expected to surpass
the number of cervical cancers by the year 2025, if the current trend of increasing trajectory of
oropharynx cancer continues to rise (Levesque, 2011).
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Because HPV replicates well in a warm, moist environment, the incidence of penile and
anal cancer can also be attributable to prolonged infection with the virus in men (CDC, 2016).
Cancer of the penis and anus occurs similarly to cancer of the cervix; if an infection of HPV is
untreated in some people with persistent high-risk HPV infections, the virus damages the cells'
DNA and causes them to start dividing and growing out of control. Although the incidence of
cervical cancer in under-developed countries far exceeds penile and anal cancer rates, in the
United States, the number of HPV related cancer rates in men, including penile, oral, and anal
cancer is increasing and is becoming comparable to the rates of cervical cancer in women (CDC,
2016).
Historically, the responsibility for contraception and prevention of sexually transmitted
infections (STIs) have largely fallen on women (Daley, 2017). In 2006, Gardasil, also known as
Silgard or recombinant human papilloma vaccine, was introduced as a revolutionary breakthrough
vaccine to prevent the occurrence of cervical cancer caused by HPV infection. The vaccine
specifically targeted the strains of Human Papillomavirus (HPV types 16 and 18) that were
identified through viral typing to be responsible for cervical cancer; (Harper, et.al., 2010).
Following the approval of the Gardasil vaccine, Merck Pharmaceuticals, the vaccine’s creator,
funded a multimedia national campaign in the United States to educate the public on the
relationship between HPV infection and cervical cancer. Merck emphasized the vaccine’s
effectiveness against cervical cancer development to women through media campaigns, even
though both men and women contribute inextricably to the spread of HPV and HPV related
cancers (Harper, et al., 2010).
In the United States, the HPV vaccination is recommended for adolescents ages 11 to
12, with catch-up vaccinations recommended through age 26. Two doses of vaccine, given 6 to 12
months apart, are recommended if the series is started before age 15. Three doses, to be completed
within 6 months, are recommended for those who started vaccination at age 15 or older (CDC,
2019). In 2019, the CDC reported that 21.5% of all young adults received the recommended
number of doses of the HPV vaccination. The percentage of females who received the
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recommended number of doses of the HPV vaccine was 35.3% and the percentage of men was
9.0% (CDC, 2019).
The developmental and implementation trajectory of the HPV vaccine since its
introduction, targeted at women, (especially young adolescent women), is suggested to have
created a gender bias. This artificial perception that males are not susceptible to acquiring HPV,
and therefore bear no responsibility in preventing its spread, has resulted in significantly lower
vaccination rates for males, thus increasing morbidity and mortality rates (Daley, 2017).
Repeated targeting of the vaccine toward women has impeded male awareness of their
vulnerability to the consequences of an HPV infection. As a result, the HPV vaccination
awareness campaign has led to the social construction of HPV and cervical cancer as a “womenonly problem”. This has led to the feminization of the HPV and ultimately may be responsible for
a lower vaccine trajectory for males.
Resulting gender biases have negative implications for stakeholders in public health as
well. The incidence of anal cancer in HPV positive men is quickly becoming comparable to the
incidence of cervical cancer, with at least 90% of all anal cancers attributed to prolonged HPV
infection (Hu, 2014). As a result, the economic burden associated with non-cervical HPV-related
cancers occurring in individuals living in the United States was approximately $418 million in
2014 (Hu, 2014). The social awareness campaign directed toward the female population has led
to the social construction of and ultimately the feminization that HPV infection is a “women-only
problem”. It has been suggested that this has contributed to a lower vaccine trajectory for males
(Daley, 2017).
Purpose of the Study
The purpose of this study was to assess whether gender differences existed in
knowledge, attitudes, beliefs, subjective influences and perceived behavioral control about HPV,
and the intention to obtain the HPV vaccine among a sample of university students.
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This study sought to understand whether lack of awareness about the consequences of
HPV (including knowledge, attitudes, effect of peer social norms) would predict lower intention
to obtain the HPV vaccine specifically for males. It was important to include females in the study
to compare whether there was higher knowledge, more positive attitudes and higher influence of
peer social norms that would validate whether the lower vaccine trajectory in male in college
students is a result of less awareness of the efficacy of the vaccine for preventing HPV.
The Theory of Planned Behavior was selected as the theoretical framework to address the
purpose of the study because the constructs of the model that examine attitudes toward a
behavior, influences on attitude such as subjective norms and perceived behavioral control (the
belief in one’s ability to perform a behavior) on behavioral intention. In the present study, the
intent to behave was measured by the the number of “yes” responses to obtain the HPV vaccine.
The current study is comparable to a study performed by Fisher, et al. (2016) in that intention
was studied as a key determinant for whether or not college students were vaccinated against
HPV. Statement of the Problem
Although the Human Papillomavirus (HPV) vaccine has the potential to prevent mortality
and morbidity from male reproductive organ cancers, the implementation trajectory of the
vaccination has focused on females, potentially creating gender biases about HPV prevention
through obtaining the HPV vaccine.
The theoretical framework used to guide the current study was the Theory of Planned
Behavior (TPB) (1991).The Theory of Planned Behavior (TPB) is a behavioral theory that is used to
predict behaviors across a wide variety of domains, including health behaviors such as vaccine uptake
(Glanz, 2011). TPB was developed by Icek Ajzen (1985) as an extension of the Theory of Reasoned
Action (TRA) which posits that the most important determinant of behavior is behavioral intention
(Ajzen & Fishbein, 1980). TPB adds an additional dimension of perceived control over a behavior. The
TRA and TPB further assert that direct determinants of an individual’s behavioral intention are
subjective norms associated with a behavior, as well as the individual’s attitude
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concerning a behavior (Ajzen & Fishbein, 1980). Other studies that used the TPB with
college populations will be examined as well as studies that specifically used TPB to examine
HPV knowledge and intention to be vaccinated.
The constructs of the theory and their specificity to HPV vaccine uptake are listed below:
1. Behavioral Intention: The motivational factors that influence behavior or, in other words, the
intentions to obtain the HPV vaccine. The stronger the intentions of the individual to get
vaccinated, the more likely they will do so.
2. Attitude Toward a Behavior: The extent in which a person will have a favorable or
unfavorable outcome about HPV vaccine uptake. A person’s attitude, in this case, consists of
behavioral beliefs that obtaining the HPV vaccine would prevent him from acquiring HPV and
developing cancer.
3. Subjective Norm: Social pressure to perform a behavior or not. In the case of HPV
vaccination uptake among males, the ideology of the feminization of the Human Papilloma
Virus as a barrier to vaccination uptake among males will be assessed.
4. Perceived Behavioral Control: Refers to perception of the ease or difficulty of obtaining
an HPV vaccination.

1. Is there a difference in knowledge about HPV between male and female college students?
2. Is there a difference in attitude between males and females toward obtaining the HPV vaccine?
3.

Is there a difference in influence of others between males and females toward obtaining the HPV
vaccine?

4. Is there a difference between males and females on their perceived behavioral control to
receive the HPV vaccine?
5. Is there a difference between males and females on their intentions to receive the HPV vaccine?
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Delimitations
The study will be delimited to students attending a university with multiple campuses in
Southeast Georgia. The study will be conducted during one semester. The surveys will be
completed during class time in the presence of peers, therefore, there is a risk of response bias
due to self-reporting. The study may not be indicative of attitudes and intentions regarding HPV
of the entire college student population in Southeast Georgia due to difference in the location of
the two campuses that will provide the sample. One campus is rural and the other urban which
may demonstrate differences in attitude and intentions regarding HPV. It will be assumed by the
researcher that all students completing the survey understood all questions and answered
honestly about sexual activities and beliefs about HPV and HPV testing.
Definition of Terms
HPV- (human papillomavirus) is a virus that can cause certain cancers and diseases in both
males and females.
Gardasil- (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and boys
ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by nine
types of HPV.
Feminization of a health issue-The strong social and cultural perception of a health topic as
a “women’s only” issue.
Gender Bias-unfair difference in the treatment of men or women because of their sex .
Cervical cancer-A type of cancer that occurs in the cells of the cervix (the lower part of the
uterus that connects to the vagina).
Theory of Planned Behavior-The Theory of Planned behavior is a theory-based framework for
understanding the multifaceted and interactive effects of personal and environmental factors that
determine behaviors, and for identifying behavioral and organizational leverage points and
intermediaries for health promotion within organizations.
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Significance of the Study
The study replicated previous studies using the TPB to understand barriers to obtaining
the vaccine that prevents HPV among both male and female university students. By conducting
research on the knowledge, attitudes, and perceived behavioral control toward HPV and HPV
vaccinations among male college students, health educators will gain insight into perceived
barriers to vaccination in this population. Findings from the study will assist health education and
promotion efforts on college campuses by developing educational strategies that address barriers to
students to obtaining the HPV vaccine.
Chapter 1 Summary
The purpose of this study is to assess knowledge and attitudes toward the HPV
vaccination and their influence to serve as a barrier to HPV vaccine acquisition among a sample
of university students. In Chapter 2, a literature review will be presented including a historical
perspective of cervical cancer and the introduction of Gardasil. The studies reviewed also include
research on the feminization of HPV and HPV related cancers. Chapter 3 contains methodology
used to accomplish the purpose of the study. The results of the study will be discussed in Chapter
4. Chapter 5 will contain a discussion of the results, conclusions drawn as a result of the study,
and implications and recommendations for further study.

15
CHAPTER 2
REVIEW OF LITERATURE
The purpose of this study was to assess gender differences in knowledge and attitudes
about HPV and how these constructs influence the intention to be vaccinated among a sample of
university students.

This chapter reviews literature on the Human Papilloma Virus (what it is, how it is
transmitted), differences of HPV prevalence in males and females, male reproductive cancers that
result from HPV infection, a brief history of cervical cancer, studies addressing use of Gardasil,
the vaccine available to prevent HPV, studies addressing gender bias in promoting the vaccine
primarily to women, leading to the feminization of HPV and the vaccine, which may have
impacted vaccine uptake, and studies examining sexual behavior that have used the Theory of
Planned Behavior to explain vaccine uptake in adolescents and young adults.
What is Human Papillomavirus (HPV) and How it is Transmitted?
The clinical definition of HPV states that it is a virus that can cause abnormal tissue
growth and other changes to cells in humans (CDC, 2017). More than 40 types of the virus are
spread by sexual contact from the skin, mucous membranes of an infected individual to the skin,
and mucous membranes of their sexual partners. Any individual who is sexually active can be
exposed to HPV through skin or membrane contact of the mouth and throat, anus, vulva, or penis
(CDC, 2017). This makes HPV particularly dangerous as it can be spread even in the context of
what are traditionally considered “safe sex” behaviors, such as using condoms or engaging in
outercourse (CDC, 2017).
Over 150 types of HPV viruses, ten have been identified as oncogenic (CDC 2016).
From these 150, at least 40 are spread through sexual contact (Cutts, 2007). The acquisition of
HPV is common; most sexually active individuals in the United States are infected with HPV at
some point. About 90% of the individuals infected with HPV do not present with any clinical
symptoms after two years and thus, do not develop cancer (Cutts, 2007). However, some HPV
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infections can progress for years and, if left untreated, can lead to the development of
cancer (Cutts, 2007).
In 2010, the Human Papillomaviruses (HPV) were the most common cause of
reproductive tract cancers which includes, penile, anal and vulvar cancers (CDC, 2011). HPV has
also been linked to oropharyngeal cancers for both men and women. Thought to be the most
prevalent type of sexually transmitted disease in the United States, most HPV infections do not
lead to cancer. The CDC estimates that the prevalence of genital infection with any HPV type
annually is 42.5% among United States adults aged 18–69 (CDC, 2014). Most of these infections
are asymptomatic and appear to resolve spontaneously within a few years. However, almost of
all cervical and anal cancers are caused by exposure to HPV (CDC, 2014).
HPV can be categorized into two groups: low-risk HPVs and high-risk HPVs. Lowrisk HPVs can cause condylomata acuminate, or skin warts, but do not cause cancer. Two lowrisk HPVs, types 6 and 11, can also cause recurrent respiratory papillomatosis, a less common
disease in which benign tumors grow in the air passages leading from the nose and mouth into
the lungs (CDC, 2017).
Two types of HPVs that are oncogenic and specifically related to the development of
cervical cancer are types 16 and type 18 are also known as High Risk HPVs. (Thompson, 2014).
The spread of HPV occurs through contact with infected skin of the genitals, mucous membranes,
and bodily fluids. The virus lives in the body’s epithelial cells located on the skin’s surface, as
well as on the surface of the vagina, mouth, anus, cervix, penis, and the back of the throat
(Thompson, 2014). The World Health Organization (WHO), states that early infections of HPV
can be detected by slight changes in the epithelium that are discovered by using virologic and
cytological techniques screening (WHO, 2014).
History of Cervical Cancer Detection
In 1941, Georgios Papanicolaou, a Greek gynecologist in collaboration with Herbert
Frederick Trau, developed a test using exfoliative cytology in which the examination of vaginal
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smears could be completed. As a result, they determined that cervical cancer could be detected by
inspecting cervical cells (Harper, 2010). The test was named the Pap smear after Papanicolaou.
This revolutionary breakthrough in women’s health was enthusiastically adopted by gynecologists
for use with their female patients. As a result, the cervical cancer rate in the United States dropped
to about half of what it was at the turn of the century. In terms of precancers and early cancers
detected, it remains the most successful screening test ever introduced for preventing serious
malignancies. Since the 1950s, mortality rates for cervical cancer have fallen approximately by
60%. However, it would be another forty years before the correlation between HPV and cervical
cancer was established (Harper, 2010).
For decades, the epidemiological profile of women with cervical cancer was recognized as a
direct result of a sexually transmitted process, and several infectious agents were proposed over the
years as a catalyst to cervical cancer: syphilis, gonorrhea, and type 2 herpes simplex virus (Bosch,
2002). In a recent article, the researchers stated that the persistence of a genital infection generated by
high-risk oncogenic HPV in cervical cells induces precancerous cervical lesions,

regardless if women have normal immune systems or not (Anouar et al., 2020). Another recent
study posited that certain genotypes of HPV are not only the necessary cause of cervical
cancer, they are also the etiological cause of some anogenital and head and neck carcinomas
(Guimera, Alemany, Bruni, & Muñoz, 2020).
The story of Henrietta Lacks, a young Black woman who was diagnosed with cervical cancer
in 1951, drew attention to the quick progression of late diagnosed cervical cancer. At the time of Mrs.
Lacks’s diagnosis, the etiological correlation between HPV infection and cervical cancer had not yet
been established. However, the cells that were removed from Mrs. Lacks’s biopsy of the tumor found
in her cervix would be instrumental to the discovery that HPV was the oncogenic agent in almost all
cervical cancer cases worldwide (Bosch, 2002). In fact, the cells labeled HeLa (the first two initials of
her first and last name) became the first human cell line that was successfully grown in culture
(Bosch, 2002). From this initial sample, The HeLa cell line has
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been in continual use in labs around the world for 65 years and has been instrumental for disease
eradication and the production of vaccinations (Bustamam, 2017).
Heralded as the first ever identified “necessary cause” of a human cancer, the correlation
between HPV infection and cancer was thought to be as important as the association between
smoking and lung cancer that was proposed by Harald zur Hausen, a German virologist and
professor (Bustamam, 2017). In other words, the concept of a cause and a consequence (cervical
cancer) implies that cervical cancer does not, and will not, develop in the absence of the persistent
presence of HPV. In the early 1990s, the International Biological Study on Cervical Cancer group
was set up to look at cervical cancer cases worldwide. After obtaining samples from women
diagnosed with cancer in 22 countries, HPV was found in at least nine out of every ten cervical
cancer samples, and this figure was consistent across the globe (Bustamam, 2017). In the study by
Anouar Tadlaoui, et. al., it was also established that two types of the HPV virus (HPV16 and
HPV18) was found in 82% of the cervical cancer cases as causative agents (Anouar
Tadlaoui.et.al., 2020).
Following the discovery in the 1980s by Harald zur Hausen that most cervical cancer
cases were caused by prolonged HPV infection, researchers at the National Cancer Institute
discovered that the proteins that form the outer shell of HPV could form particles that closely
resemble the original virus and create high levels of potentially protective antibodies. The particles
were not infectious, because they lacked the necessary viral genes. The virus-like particles
subsequently became the basis for Gardasil, a new vaccine that was in development (Bustamam,
2017). In recent times, the virus-like particles that are based on L1 proteins have been considered
as the best candidate for vaccine development against HPV infections (Namvar, Bolhassani, Javadi,
& Noormohammadi, 2019).
The Introduction of Gardasil
Introduced and licensed by the United States on June 8, 2006, Gardasil was a new vaccine
to prevent the acquisition of HPV and the first vaccine designed to guard against cervical
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cancer (Lexchin, 2010). According to the CDC, the Food and Drug Administration (FDA) first
approved first-generation Gardasil, which prevented infection of four strains of HPV: 6, 11, 16, and
18. In December 2014, Gardasil9 was approved by the FDA. This vaccine protects against 9 strains of
HPV: the four strains approved in the previous Gardasil vaccine, as well as 31, 33, 45, 52, and

58. The FDA recommended the vaccine for girls aged 9–13 years, or before the onset of sexual
intercourse, and women aged 14–26, even if they had previous abnormal Pap smears or HPV
infections (Lexchin, 2010). Uptake of the Gardasil vaccine consists of a three dose, quadrivalent
process. The vaccine is currently approved in 123 countries, is prophylactic and contains viruslike particles of HPV types that stimulate type-specific neutralizing antibodies (CDC, 2011).
A systematic review was performed by Rambout and colleagues to test the efficacy of the
vaccine among women aged 15-25 years not previously infected with vaccine-type HPV strains.
Because HPV is known as the necessary cause for cervical cancers and prophylactic HPV vaccines
are designed to prevent genital warts, precancerous cervical lesions and cervical cancer, the
researchers wanted to gauge the potential impact of vaccine uptake on disease burden in the United
States. The researchers conducted a systematic search of literature obtained through an online
database search to identify all randomized controlled trials of prophylactic HPV vaccination
between 2006 and 2007. Findings from the systematic review showed that prophylactic HPV
vaccination was associated with a reduction in the frequency of high-grade cervical lesions caused
by vaccine-type HPV strains when compared with control groups. It was concluded that the
efficaciousness of the vaccine appeared to be high, and the incidence of adverse effects from the
vaccine were low (Rambout, 2007).
Markowitz, et.al., (2013) examined HPV vaccine uptake comparing data from the time the
vaccine was introduced (2007-2010) with data collected in the pre-vaccine era (2003-2006) in a
National Health and Nutrition Examination Survey (NHANES). NHANES reported that in a group of
females between the ages of 14-19, only 34% were vaccinated during 2007-2010, an 11.6% decrease in
comparison to females in the same age group that were vaccinated between 2006-2007.
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However, the type of HPV prevalence that are covered by vaccinations decreased by approximately
56%, a phenomenon that was examined by the researchers in the study (Markowitz, 2013)
Because there were no mitigating factors such as changes in sexual behavior among the
participants, the researchers suggested that an early uptake impact of the vaccination could be the
reason behind low HPV prevalence among this age group due to herd immunity, vaccine
effectiveness of a series involving <3 doses, and/or changes in sexual behavior that was not
measured (Markowitz, 2013). However, because the data was self-reported, under or over reporting
could have skewed results in the study. Considering the substantial health and economic burden of
HPV associated diseases, this study is encouraging in that it reinforces the effectiveness of the
vaccine (Markowitz, 2013)
The Human Papillomavirus Infection in Men
There is empirical evidence that male HPV infection contributes significantly to the
transmission of the virus in women which subsequently can lead to cervical cancer. In a casecontrolled study of women with cervical cancer by Giuliano, et. al., it was established that a
woman’s husband’s sexual behavior affects her risk of cervical neoplasia, even when controlling
for female sexual activity (Giuliano, 2008). More recently, however, researchers have ascertained
that HPV contributes to men's burden of diseases such as anal, penile, and oropharyngeal cancers.
Many men are unaware of the HPV related cancers that are exclusively developed as a direct
result from a prolonged infection with the Human Papilloma Virus (Daily, 2017).
Along with penile, anal, and oropharyngeal cancers, there are other HPV related diseases
such as condylomata acuminata (genital warts) and recurrent respiratory papillomatosi that are of
clinical significanc to men. It is important to note that per Giuliano, an HPV infection in men may
increase the risk of acquiring human immunodeficiency virus (HIV) infection as well, because
their inflammatory response to HPV may make their target cells more receptive to HIV (Giuliano,
2008).
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Per Giuliano, it was noted that while relatively little is known about the epidemiology of
HPV infection in heterosexual men, an understanding of HPV infection and associated disease in
these men has assumed increasing importance because the efficaciousness of the vaccine Gardasil
(Giuliano, 2008). It has been proven to be highly effective in preventing HPV types 6, 11, 16 and
18 which most frequently affect men. However, despite the vaccine’s availability for men, only a
few countries have implemented vaccination programs for men. In 2013, Australia became the
first country to initiate government funded universal HPV vaccination programs for boys and
began including boys in a national school-based HPV vaccination uptake (Newman, et. al, 2014).
As Giuliano points out, lack of knowledge about the transmission of HPV, as well as the severity
of the types of subsequent cancers specific to men, can be the catalyst to low male vaccination
uptake and implementation of HPV vaccination programs for boys (Giuliano, 2008). A study by
Pitts, et.al., (2017) also pointed out that the lack of males’ knowledge about their role in the spread
of HPV, as well as lack of awareness about the HPV vaccination continue to be significant barriers
to males receiving the vaccination.
The cost-effectiveness of HPV vaccination in males
While research has established a strong causal link between specific types of HPV infection
and cervical cancer, fewer studies have been conducted on HPV infection in male reproductive organ
cancers. Yet, the incidence of anal cancer in HPV positive men is quickly becoming comparable to the
incidence of cervical cancer, with at least 90% of all anal cancers being a direct result of prolonged
HPV infection (Hu, 2014). According to the Centers for Disease Control and Prevention (CDC) in
2019, about 6,810 men were diagnosed with anal cancer and about 91% of those cancers were thought
to be caused by HPV. The resulting economic burden associated with non-cervical HPV-related
cancers occurring in individuals living in the United States was approximately $418 million in 2014
(Hu, 2014). In another study by Wu, et.al., in 2018, it was found that the first two year per patient
adjusted mean cost associated with anal cancer treatment was $127,531. Interestingly, because most
economic studies to date of HPV related
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conditions have focused primarily on cervical cancer, there are substantially fewer costing
studies of noncervical HPV associated sequelae, or male cancer development (Hu, 2014).
In 2013, there were approximately 500,000 new cases of anogenital warts reported to the
Centers for Disease Control and Prevention (CDC) (CDC, 2015). In a study conducted by the CDC
the researchers sought published estimates of the cost per episode of newly diagnosed genital warts
because a single episode of anogenital warts is often associated with the use of a combination of
different therapies, and there is wide variation in cost among the different treatment options. A
study conducted during the introduction of the HPV vaccination found that women enrolled in a
United States health care plan estimated that an average of $26,415 per 1000 women was spent on
annual cervical screening and treatment for HPV-related diseases (Soper, 2006). In 2019, according
to the CDC, about $1 billion was reported for cancer related treatments, including $0.4 billion for
cervical cancer and $0.3 billion for oropharyngeal cancer. Furthermore, the treatment for
anogenital warts in 2019 was approximately $0.4 billion in the United States alone. Taking into
consideration all the combined therapies, in the United States the estimated lifetime total medical
cost of HPV infection for men and women ages 15–24 is $2.9 billion, which makes HPV the
second most expensive STI after human immunodeficiency virus (HIV) (Soper, 2006).
Penile and Anal Cancer
The acquisition of anal cancer primarily caused by an HPV infection is comparable to that
of HPV associated cervical cancers (Bennett, 2015). Because there is a similarity of the tissue of the
anal canal, including a transformation zone that is bounded on each side by squamous and columnar
epithelium, HPV induced carcinogenesis leading to cervical cancer is comparable to the process that
leads to anal canal cancer (Levesque, 2011). About 91% of all anal squamous cell carcinoma cases in
the United States can be directly attributed to HPV infections. There are approximately 693 women
and 377 men diagnosed with HPV associated anal cancers each year (Bennett, 2015). Although anal
cancer is less common than cervical cancer, its incidence in men
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residing in the United States is increasing and is expected to be the most commonly
diagnosed anogenital HPV associated cancer in 2020 (Bennett, 2015).
Penile cancer is a rare malignancy of the genitourinary tract, with 0.58 per 100,000 men
in the United States affected by the disease. However, exposure to HPV has been detected in
nearly one half of all cases of penile cancer (Fernandez, 2014). Because penile cancer is rare in the
United States, it is wholly under-researched. However, it has been established that the disease is
associated with high mortality and significant adverse effects after treatment. Because treatment of
penile cancer often leads to genital disfigurement, psychological and emotional distress are
common side effects. Depression and anxiety are common after-effects post-treatment as well
(Fernandez, 2014). The Epidemiology of Oral HPV Transmission
The findings by Sonawane, et.al, (2017) that oral HPV begins with sexual debut,
supports the idea that the acquisition of oropharyngeal cancer is strongly associated with sexual
behavior beginning at adolescence. Per Sonawane et.al., (2017) the transmission of oral HPV
occurs after performing oral sex on infected genitals. The research is unclear as to whether oral
HPV can be spread through deep kissing. Through a study performed on a couple who both
presented with oral cancer, identical HPV strains were identified, supporting the hypothesis of oral
HPV transmission between the couple (Sonawane et.al., (2017). It was further discovered that
partners of women with cervical cancer have a higher incidence of oropharyngeal cancer than the
general population, supporting the hypothesis that the transmission of HPV from the genital region
of an infected woman is possible to a partner during oral sex (Sonawane, 2017).
Because sexual behavior is strongly associated with oral HPV acquisition, Sonawane,
et.al., sought to examine a link between adolescent sexual behavior and oral HPV. Most of the
surveys the researchers conducted on a sample of teen-aged participants about adolescent sexual
behavior, indicated that a significant proportion of the adolescents engaged in oral sex prior to
vaginal intercourse, and perceived oral sex as less risky (Sonawane, 2017). The participants
indicated that they had more oral than vaginal sex partners as well. According to data from a 2016
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survey performed by the National Survey of Family Growth, 38.8% of males and 43.6% of
females aged 15 to 19 years residing in the United States have performed oral sex. In addition,
approximately 12% of males and 10% of females in this age group have had oral sex but not
vaginal intercourse (Sonawane, 2017).
The incidence of HPV positive oropharyngeal squamous cell carcinoma (OPSCC) is
disproportionately higher among men residing in the United States in comparison to women
(Sonawane, 2017). There are approximately 11 million men residing in the United States with
OPSCC and 3.2 million women. Men also have a 5.4% greater probability of high-risk oral HPV
infection than women. The incidence of high-risk oral HPV infection is exacerbated by men who
smoke more than 20 cigarettes daily and are current marijuana users. There is also a higher
prevalence rate among African American males and those who report 16 or more lifetime vaginal
or oral sex partners (Sonawane, 2017).
No data is available on the costs for anal cancer rates in the United States, however, the
researchers used a comparable study for anal cancer conducted in Canada to ascertain the
economic burden for anal cancer in the United States (Hu, 2014). There are approximately 693
women and 377 men diagnosed with HPV associated anal cancers each year in the United States
(Bennett, 2015). About 91% of all anal squamous cell carcinoma cases in the United States can be
directly attributed to HPV infections. Because the rates for developing anal cancer are increasing at
a rapid pace each year in the U.S., the study that was done in 2015 is not quite indicative of the
actual economic burden in the United States for anal cancer. However, the researchers estimated
the total lifetime cost of all HPV attributable incident cases of anal cancer occurring in 2015 to be
$92 million with a range of $44 to $178 million (Hu, 2014).
The cost estimates for penile cancer are of interest for the current study about barriers
to male vaccination because the American Cancer Institute (ACI) estimates that there are at least
2,120 new cases of cancer to the penis diagnosed annually, resulting in 360 deaths each year.
Nearly all cases of penile cancer can be directly attributable to HPV infection (ACI, 2017). The
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costs related to penile cancer include a primary care physician visit, surgery, anesthesia,
hospitalization, radiation, chemotherapy, and visits with a specialist (Hu, 2014). Reconstructive
therapies were not addressed. Taking all the therapies combined into consideration, the cost of
penile cancer per year in the United States is approximately $8.6 million (Hu, 2014).
The results of the study of cost analysis by Hu prove that there is a substantial economic
burden in the United States due to HPV acquisition and related cancers for males. However, the
study did not take into consideration non-clinical costs to the public, such as transportation costs to
healthcare facilities or the value of work time lost receiving health care. There is also the issue of
HPV positive males transmitting the virus to females, subsequent disease acquisition and economic
burden for females that was not addressed in this study as well. A study performed by Gargano, et.
al. gave a more thorough statistical analysis of health outcomes for females who were exposed to
HPV and were diagnosed with invasive cervical cancer. In 2012, there were over 500,000 new
cases and 265,000 deaths attributable to cervical cancer. The study discussed other significant, noncervical health outcomes for females that had been exposed to HPV as well. The largest proportion
of cancers for females directly attributable to exposure to HPV between 2009-2013 were anal
cancers (about 90%), followed by vaginal cancers (about 75%), oropharyngeal cancers (about
70%), vulvar cancers (about 70%), and penile cancers (about 60%) (Gargano, 2017).
Vaccine Efficacy for Males
It was not until 2011, that recommendations by the advisory Committee on Immunization
Practices recommended routine vaccinations for males (Markowitz et al., 2013). There are two
significant categories related to the importance of HPV vaccine uptake in men: reduction of
disease burden for males and reduced transmission of the virus to women (Quinn, 2015). Because
it has been empirically established that HPV is spread through sexual contact, vaccination of males
has the advantage of reducing the risk of HPV transmission to sexual partners, as well as reducing
the spread of HPV in the general population and ultimately, HPV related cancers for both men and
women (Quinn, 2015).

26
Although the most common cause of mortality related to HPV is cervical cancer, the
disease burden for HPV-related cancers for men is becoming significant. Anal cancer rates are
rising due to an increase in HPV acquisition and have more than tripled since the 1970s. Although
males who have sex with other males (MSMs) are at a higher risk for the development of anal
cancer, the incidence of anal cancer in heterosexual men is increasing, with about 2% more cases
diagnosed each year (Quinn, 2015). Because acquisition of HPV is directly responsible for the
development of at least 90% of all anal cancers, HPV vaccine uptake among males is imperative to
prevent HPV infection (Quinn, 2015). Despite eligibility to receive catch-up doses up to age 26
years, low HPV vaccination rates leave a large population of college-aged males unprotected.
The incidence of genital HPV infection among men is similar to that among women
(Quinn, 2015). The transmission of HPV is common, and the median clearance time of infection is
approximately six months. The peak rise of any HPV infection is approximately ten years from the
first sexual experience for both men and women. There are at least 40 types of the more than 100
types of HPV that have been identified that affect the genital tract; however, as in the case of
cervical cancer for women, types 18 and 16 are the oncogenic types that cause nearly all anal,
penile, and oropharyngeal cancers in men (Quinn, 2015). An article by Senkomago, et.al., (2019)
stated that recently, it has been discovered that oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58
are causally attributable to nearly all cervical cancers and some cancers of the vagina, vulva, penis,
anus, and oropharynx
Long term infection for both men and women can cause both benign and malignant
anogenital disease, as well as head and neck lesions (Quinn, 2015). However, in clinical trials, HPV
vaccinations were safe and are 90% to 100% effective against persistent infection with HPV types 6
and 11 and genital warts in women and men. Furthermore, although Gardasil uptake was first
recommended for individuals between the ages of six and eleven, the Food and Drug Administration
(FDA) approved a prophylactic quadrivalent HPV vaccine in 2006 for females between the ages of 9–
26 years and in 2009, approved the same vaccine for males of the same age

27
group. Individuals receiving the prophylactic quadrivalent vaccine found the vaccine efficacious in
reducing more than 90% of external genital lesions and approximately 90% efficacious in
preventing persistent infections caused by the HPV types covered in the vaccine, including the
oncogenic types 16 and 18 (Quinn, 2015). This information is critical to the current study in that
our sample contains college-aged individuals.
Gender Norms Influential in Male Vaccine Uptake
Prior to Gardasil being approved, Merck pharmaceuticals narrativized the vaccine as a
women’s only health issue through awareness campaigns linking the vaccine to cervical cancer,
even though medical research has ascertained the role of men in HPV transmission (Stanley,
et.al., (2017). Misperceptions of men about their role in HPV acquisition and transmission
disproportionately affects decisions concerning vaccine uptake, as well as causes gender
discourse in responsibility for prevention in sexual matters (Stanley, 2017).
In the book “The Vulnerable Empowered Woman: Feminism, Postfeminism, and
Women’s Health,” Tasha Dubriwny discusses the dynamics of public discourse concerning HPV
and public history of burdening women with the responsibilities of providing preventative
measures regarding STIs and pregnancy (Dubriwny, 2012). Dubriwny agrees with Stanley in that
the initial trajectory of the Gardasil vaccination aimed at eradicating cervical cancer, further
ingrained the notion of HPV prevention as a “women’s only issue,” even though the nature of the
commercials were supposed to empower women. Even the inclusion of young men into HPV
vaccination campaigns would have little or no effect on public discourse about the overall message
concerning HPV and sexuality according to Dubriwny. The idea that women will not be thought of
as having high moral standards if they contract a sexually transmitted disease such as HPV has
historically been considered a social norm. Even if they lessen their chances by becoming
vaccinated, their reputations are still at the mercy of their “risky” sexual behavior and the
“dangerous” men with whom they associate (Dubriwny, 2012).
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Stanley (2017) discusses the constructs of the self-categorization theory; particularly, the
social shift of social identity that is built on contrasting one’s ingroup with a relevant outgroup
and its meaningful consequences for group member’s perceptions, attitudes, and behaviors. In the
case of HPV prevention and vaccine uptake, men adhere to perceived social perceptions and
norms concerning responsibility of sexual issues, simply because men value gender as a social
identity more than women do, as reflected in stereotypical gender norms pertaining to masculinity
and public health issues (Stanley, 2017). Men who adopt a stronger, traditional role of
masculinity, and who perceive other men of not engaging in health promoting behavior, typically
perform fewer healthy behaviors themselves (Stanley, 2017).
Low male HPV vaccination uptake illustrates the influence of gender discourses and
norms, as well as identifies concerns that males may have about emasculation towards vaccine
uptake (Stanley, 2017). Misperceptions among males who recognize HPV vaccination uptake as
a women’s issue can cause them to reject inquiring about HPV and other feminized sexual health
issues with their healthcare provider. Male perceived denial of vulnerability, compounded by the
fact that more women seek medical advice than men, can create provider bias and consequently,
healthcare provider preference for vaccinating women (Stanley, 2017).
Even though discourse identifies women as the most vulnerable when it comes to
negative outcomes of sexual activity, most college men envision an ideology that women and men
are equal concerning sexual health (Stanley, 2017). However, most men recognize that,
realistically, women are more responsible, even though most men agree that men are more
sexually active and engage in higher risk sexual activities. Perceived knowledge about sexual
health was cited in Stanley’s study as well. Most men believed that women have a greater access to
sexual knowledge through their mothers, and that fathers felt too much discomfort to discuss
sensitive sexual material with their sons. Because there are discrepancies in the parental
knowledge afforded to sons and daughters, resulting normative referents among male peers dictate
a lack of accountability of men concerning sexual health (Stanley, 2017).
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Intentions of Men to Receive the HPV Vaccine
While the incidence for cervical cancer has decreased, the incidence of HPV positive
anal cancer has been rising in men who have not participated in vaccine uptake (Gilbert, 2010).
Because the early marketing of Gardasil specifically targeted females, gender bias toward HPV and
HPV related cancers has become the perceived norm, causing the “feminization” of HPV (Daley,
2017). Even though clinical trials of Gardasil indicate that the vaccine can significantly prevent
anal cell changes acquired by prolonged HPV infections, the perceived feminization of HPV and
HPV related cancers could cause lower vaccination rates for men when compared to women
(Gilbert, 2010).
In a study performed with a university sample by Gilbert, et.al., a comparison was made
between heterosexual and gay men toward receiving an HPV vaccine. The authors sought to glean
information about HPV vaccine awareness, knowledge, and attitudes in comparable samples of
heterosexual and gay men. The researchers had hypothesized that most of the male participants
would not have heard of HPV or related cancers for men (Gilbert, 2010). As expected, most of the
participants had not heard of male roles in the spread of HPV, and most males were unaware of a
vaccine for the prevention of HPV (Gilbert, 2010). These findings further corroborate our
hypothesis that knowledge among males about HPV and related cancers is limited.
After extensive exposure to information about HPV and related cancers among men,
receptiveness of the vaccine varied substantially among the groups examined; 94% of gay males
who had significant exposure to HPV related information through the study intended to vaccinate
against HPV, regardless of whether a safe and effective vaccine was available, compared to 62%
of heterosexual university males who were willing to consider HPV vaccination (Gilbert, 2010).
Our hypothesis about negative attitudes towards HPV vaccination among heterosexual males
appears to be substantiated by the lower willingness for vaccine uptake among this group.
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Gender Bias and HPV Infection
Gender bias towards HPV acquisition is exacerbated by the fact that there is not a
screening test for HPV available for men; there is only a visual inspection for clinicians to check
for lesions or warts on males (Daley, 2017). There is no specific way to test directly for HPV in
men that is approved for clinical use. The only approved tests on the market for primary,
preventative care for HPV are for screening women for cervical cancer, which further reinforces
the ideology that women are responsible for HPV prevention. Because females are burdened
with both the primary and secondary prevention of HPV, males fail to receive adequate
preventative measures of HPV acquisition; further increasing the likelihood of acquiring HPV
related diseases (Daley, 2017).
Males can suffer numerous consequences from gender bias that could mislead them about
who is more likely to spread HPV. This type of bias, often referred to as the feminization of an
issue, occurs when the social construction of the issue is directed toward females. Since the
introduction of the HPV vaccine Gardasil, the implementation trajectory has been focused on the
vaccine’s usefulness in preventing cervical cancer, even though the burden of HPV acquisition
does not disproportionately affect one gender over the other (Daley, 2017). Direct and indirect
gender biases and inequities for HPV vaccine uptake can be partially attributed to the specific focus
of Gardasil manufacturers on females.
In the case of HPV, the feminization of HPV and HPV related cancers was that if
vaccination rates for HPV in females were adequate, herd immunity could be achieved, thus
absolving males for HPV prevention responsibilities (Daley, 2017). However, HPV vaccination
rates for females residing in the United States are nowhere near achieving herd immunity threshold.
Furthermore, the herd immunity ideology does not take into consideration men who have sex with
other men (MSM) (Daley, 2017). Per Daley, the sub-group of MSM does not receive enough
protection from HPV, even though clinical trial data among MSM who have been vaccinated with
4vHPV demonstrate a reduced risk of anal cancer and oropharyngeal cancers. Because this
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subgroup has a higher rate of these types of cancers, missed opportunities for vaccine uptake among
can result in increased morbidity and mortality among HPV positive MSM (Daley, 2017).

The concept of gender bias occurring when the social constructs of an issue become
feminized is not a new phenomenon. The historical concept of feminization can be traced back
to the 1970s, when issues of equal pay for women, as well as complex social reconstruction
issues such as women taking on new roles as breadwinners, has helped to shape the concept of
gender bias (Daley, 2017).
The transmission of the virus can debunk the idea of gender specificity of HPV and
related cancers itself. HPV acquisition can only occur through sexual contact, which includes skin
to skin contact, genital to skin contact, and oral to genital contact, implying that it is necessary for
an individual to have contact with another person to acquire the virus (Daley, 2017). Furthermore,
it is estimated that nearly 85% of women and 91% of men, with at least one sexual partner from
the opposite sex, will contract HPV infection during their lifetime. It is estimated that more men
acquire HPV through heterosexual transmission than women as well (Daley, 2017).
The Theory of Planned Behavior Related to College Students and HPV Vaccination Rates The
Theory of Planned Behavior (TPB) was chosen for this study because university

students were studied to see if their decisions to be vaccinated or not against HPV was influenced
by their knowledge about HPV, their attitudes toward HPV vaccination, their perceived
behavioral control toward receiving the vaccine and their intention to do so.
The Theory of Planned Behavior (TPB) has been used to predict behaviors across a wide
variety of health behaviors (Glanz, 2011). TPB was developed by Icek Ajzen (1985) as an
extension of the Theory of Reasoned Action (TRA) which hypothesizes that the most
important determinant of behavior is behavioral intention based on an individual’s attitude and
subjective norms toward a behavior (Ajzen & Fishbein, 1980). The additional dimension of
perceived control is the perception of the difficulty of performing or completing a behavior.
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A study performed in 2019 (Preston & Barrow) utilized the Theory of Planned Behavior
(TBP) to examine differences in HPV related knowledge, attitudes, and practices among men and
women attending college in south Florida. The researchers used the constructs of the TPB to
make a direct correlation to vaccine uptake among males and knowledge and attitudes influencing
positive intention toward receiving the vaccine (Preston & Barrow, 2019).
After assessing knowledge about HPV and HPV vaccination, the study found that male
participants were significantly less aware of HPV vaccine age recommendations than the female
participants were. The researchers stated that low awareness about HPV vaccination could be
because Florida public schools have adhered to an abstinence only or abstinence-based sexual
health curriculum (Preston & Barrow, 2019).
The study also examined differences in attitudes toward HPV vaccination among men
and women. The study found that over 70% of men had not been vaccinated, and only 26% of
women and 4% of men had received all three doses of HPV vaccine, despite men reporting similar
knowledge about the vaccine as women (Preston & Barrow, 2019). The male participants with
negative attitudes toward HPV vaccination were significantly less knowledgeable in comparison to
their female counterparts about HPV and HPV vaccination and were less likely to have received
the vaccine. This finding is consistent with other studies in which it was concluded that HPV
knowledge is a predictor of favorable attitudes toward vaccination.
In another study by Catalano, et. al., the TPB’s constructs were utilized to predict
behavioral intentions of college-aged men toward receiving the HPV vaccination. The sample
consisted of college men who were at least 18 years of age. Previous awareness and knowledge
about HPV and HPV vaccination were reported as low by about one-third of the sample.
Approximately one half of the respondents indicated that they had not heard of a vaccination
against HPV until they participated in the study (Catalano, et. al., 2016).
Most of the respondents in the study indicated that they had engaged in oral, vaginal, or anal
sex. However, most of the upperclassmen reported as unvaccinated for HPV. This is troubling
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because the researchers suggested that most college men have increases in their sexual contacts
over the duration of their collegiate career, putting them further at risk for an exposure to an
HPV infection (Catalano, et. al., 2019).
Attitudes about HPV vaccinations were also assessed in the study by Catalano. The
reported means scores were low, suggesting that the respondents had unfavorable attitudes
about receiving the HPV vaccine series within the next 12 months. The researchers also found
that attitude was a significant predictor in the respondents’ behavioral intention to receive all
three doses of the HPV vaccination within the following year (Catalano, et. al., 2019).
Subjective norm mean scores for the men in the study were reported as low, indicating
that the participants did not perceive social pressure to be vaccinated against HPV. The researchers
indicated that subjective norm was the strongest predictor of behavioral intention toward receiving
the series of HPV vaccinations among the participants in the study (Catalano, et. al., 2019).
Although the means scores were slightly low for perceived behavioral control, it was not
a significant predictor toward the intention of males to receive the HPV vaccination. The
researchers suggested, however, that because respondents lacked enough knowledge about HPV
and the HPV vaccination process, they would not be able to make an adequate assessment about
what the vaccination process would entail (Catalano, et. al., 2019). Inadequate knowledge about
HPV and HPV vaccination was also a factor in low means scores for behavioral intention to
receive the HPV vaccination among the respondents. This finding is consistent with other studies in
which insufficient knowledge about HPV is directly correlated with low vaccination rates among
males (Preston & Barrow, 2019).
In a study performed by Johnson and Ogletree (2017), knowledge about HPV and
behavioral intention toward HPV vaccination among college men was assessed. A little over half of
the sample had not heard of HPV and 60% of the respondents indicated that they had not heard of
HPV vaccinations for men prior to this study. Most of the participants reported that they had a
positive attitude toward being vaccinated against HPV; however, attitudes proved not to be a
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significant predictor of the intention to be vaccinated. Both perceived behavioral control and
subjective norms were found to be significant predictors of behavioral intention among the men
to receive the HPV vaccination, however, subjective norms, or where the men received their
information about HPV and HPV vaccinations, proved to be the strongest predictor of behavioral
intention for HPV vaccine uptake (Johnson & Ogletree, 2017).
Summary
The purpose of this study was to assess whether gender differences existed in
knowledge, attitudes, beliefs, subjective influences and perceived behavioral control about
HPV, and the intention to obtain the HPV vaccine among a sample of university students.
In Chapter 2, the literature on Human Papilloma Virus including differences of HPV
prevalence, male and female reproductive cancers that result from HPV infection, studies
addressing use of Gardisil (HPV vaccine), studies addressing gender bias in promoting the
vaccine and studies examining sexual behavior that have used the Theory of Planned Behavior
to explain vaccine uptake in adolescents and young adults was presented.
Chapter 3 will contain the methodology used to accomplish the purpose of the study.
The results of the study will be discussed in Chapter 4. Chapter 5 will contain a discussion of the
results, conclusions drawn because of the study, and implications and recommendations for
further study.
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CHAPTER 3
RESEARCH DESIGN AND METHODS

This chapter presents an overview of the research methodology utilized in this study. The
setting of the study, research design, protection of human subjects, sample methodology,
instrumentation and psychometric properties (validity and reliability), and data analyses are
discussed.
Purpose
The purpose of this study was to assess knowledge and attitude about HPV, and
how attitudes influence the intention among college students to be vaccinated among a
sample of university students.
The following research questions guided the study:
1. Is there a difference in knowledge about HPV between male and female college students?
2. Is there a difference in attitude between males and females toward obtaining the
HPV vaccine?
3.

Is there a difference in the influence of others between males and females toward
obtaining the HPV vaccine?

4. Is there a difference between males and females on their perceived behavioral control to
obtain the HPV vaccine?
5. Is there a difference between males and females on their intentions to obtain the
HPV vaccine?
Setting of Study
The study setting was on two campuses of Georgia Southern University (GSU) located in
Southeastern Georgia. Georgia Southern University, Statesboro campus, is an institution with an
enrollment of 20,418 students in 2017 (Georgia Southern University, 2017). The Armstrong
campus is smaller, with approximately 7100 students enrolled in 2016 (Armstrong University,
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2016). As of January 1, 2018, consolidated Georgia Southern University overall enrollment
grew to approximately 27, 518 students.
For the 2017-18 academic year, the Statesboro campus’s student body consisted of 43.7%
males and 56.3% females, with the majority of students (94%) residents of Georgia while the
remaining 6% came from out of state or international (Georgia Southern University, 2018). More
than half (62%) of the students identify as Caucasian and 26% identify as African American
(Georgia Southern University, 2018). For the same time period, the Armstrong campus body
reported that 33.2% of students were male and 66.8% were female (Armstrong University, 2016).
The majority of students (86%) of the students were from Georgia and 14% were from out of
state or international. Almost 60% of the students self-identify as Caucasian and 25.5% selfidentify as African American (Armstrong University, 2016). The purpose of conducting the study
on both campuses is that one campus is rural, and one campus site is urban.
Study Design/Research Methodology
The study employed a quantitative approach to data collection. Specifically, a quasiexperimental, exploratory, cross-sectional research design in which data was collected. Rigorous
quantitative sampling was employed.
A stratified proportional random sample of students attending one university with
multiple campuses was implemented. Each campus site constituted a stratum, with two or
more classes of an undergraduate level randomly selected from each campus. Intact classes
were identified. To obtain a final sample size of 380 participants based on the power analysis
of p≤0.05, an initial sample of 450 students was sought (Creswell, 1997). Proportional
sampling between stratum necessitated that the Statesboro campus have at least 337
participants (74.8%) and Armstrong campus with 113 participants (25.2%) (Creswell, 1997).
Originally, the study was to include qualitative components consisting of individual
interviews to further explore and validate the quantitative responses, particularly among male
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students. Due to low participation and the inability to reach saturation required for meaningful
qualitative results, the interviews were excluded from the final data analysis and results.
Data Collection
During the Spring 2018 semester, approximately 30 faculty members were contacted
requesting permission to survey their classes. Out of the 30 contacted, 10 faculty members gave
permission for in class surveys. During the initial contact timeframe, many faculty members
indicated that their classes were online. Therefore, an electronic version of the survey was created
via Qualtrics© and the link was shared with the online instructors. Fifteen faculty members were
asked to share the online survey link with their classes; six faculty members granted permission
to survey their classes face to face. Approval for the research study was received by the
Institutional Review Board. Out of the 384 completed surveys, 95 were completed on-line;
therefore, approximately 25% of the respondents completed the survey on-line and 75%
completed the survey in person during the scheduled class time. (Appendix A). One
questionnaire was excluded from analysis due to incompleteness (less than 20% of the survey
completed), resulting in a sample size of 383. A survey was given face-to-face to the randomly
selected classes of students. After contact was made with instructors requesting their permission
to survey their classes over the summer, it was determined that many of the classes were online.
This necessitated the creation of an online version of the survey instrument and an addendum to
the IRB to reflect this additional mode of data collection. At the end of the survey instrument,
participants indicated their willingness to participate in compensated interviews to complete the
qualitative data collection. The researcher’s email address was provided for interested
participants. Numeric coding of participants was performed to maintain anonymity.
Population
The sample for this study was undergraduate students who attend a mid-sized university in
the Southeast portion of the United States. Individuals were eligible to participate in the study if they
are 18 years of age or older and a matriculated student at Georgia Southern University.

38
This study has met all criteria for the protection of human subjects and permission from
the Institutional Review Board has been granted.
Instrumentation
Quantitative Instrumentation
The instrument consists of a modified 40-item questionnaire created from a previously
established instrument (Caron, et.al., 2008 & Jasper, 2014). Content face validity was verified by
committee members and previous substantiation while internal consistency was established by
conducting a Cronbach’s alpha coefficient analysis which was reported as .69. The amount of
time to complete the questionnaire and comments of the mechanics of the questionnaire were also
recorded. Specific items were revised based on calculated results and participant feedback. Ten
questions assessed the participants’ knowledge about HPV and HPV vaccination uptake with a
closed choice response. Sample knowledge questions include: “How do you think HPV is
spread?” and “Have you ever heard of Gardasil™, a vaccine to prevent cervical cancer that was
approved by the FDA in June 2006?” Twelve questions assessed attitudes and beliefs toward the
HPV vaccination. Sample questions included “It’s not safe to get the HPV vaccine shots” and
“Getting vaccine shots against HPV would be a good way for males to protect their health.” Six
questions assessed behavior related to transmission and contracting HPV. Sample of behavioral
questions include: “What changes would you make if you found out that your partner has HPV?”
and “Do you and your partner talk about STDs?” The next set of twelve items assessed perceived
risk about the HPV vaccine and is presented on a Likert-type scale with responses ranging from
strongly agree to strongly disagree. Sample perceived risk questions include: “It is not safe to get
the HPV vaccine shots” and “HPV vaccine shots are dangerous.” At the end of the quantitative
portion of the instrument, participants were asked about their willingness to be contacted to
participate in a telephone interview.
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Figure 3.1
Data Analysis and Procedures
#

Research Questions

Variables

Variable
Classification

Statistical Test

Items
1-10

1. Is there a difference in knowledge
about HPV between males and females?

Knowledge
items
Gender
Year in School,
Age of first
sexual
intercourse,
Ever
been
vaccinated

Interval,
Total
knowledge
score

Frequencies,
Means, Standard
Deviation
Cross Tabulation
ANOVA

Items
12-23

2. Is there a difference between males and
females in attitudes toward HPV and
obtaining the HPV vaccine?

Attitude items
Gender, Year
in School

Interval,
Total
attitude score

Frequencies,
Means, Standard
Deviation
ANOVA

Items
24-28

3. Is there a difference between males and
females on the influence of others toward
HPV vaccination?

Subjective
Norms
Gender, Year
in School

Interval,
Total
influence
score

Frequencies,
Means,
Standard
Deviation
ANOVA

Item
29-48

4. Is there a difference between males and
females in intention to obtain the HPV
vaccine?

Behavioral
Nominal
intention items Interval
Gender
Year in School
Sexual Activity

Frequencies,
Logistic
Regression

40
Data Analysis
After all data was coded, frequencies were calculated for all items with additional
comparative analyses performed for specific demographic characteristics and specific categorical
variables. In order for reliable and valid measures of latent, theoretical constructs, the variables
that are related to one another were used to compute composite, or total score (Creswell, 1997). A
multiple-regression model assessed independent variables contribution to predict vaccination
intention: age (continuous, in years), cumulative knowledge (as measured by the number of
correct responses on the knowledge portion of the instrument), and attitudes towards HPV
vaccination (*see Likert portions of instrument*).
There were three primary outcomes of interest in this study: a) knowledge about HPV
and the HPV vaccination, b) attitudes toward HPV infection and the HPV vaccine and c)
perceived behavioral control concerning obtaining the HPV vaccine. All statistical analysis was
performed using the software IBM SPSS Statistics 25(v.28) (IBM Corp. Released 2017).
Summary
The purpose of this study was to assess knowledge and attitudes about HPV and how
attitudes influence the intention to be vaccinated among a sample of university students. In
Chapter 2, a literature review was presented relating to the perceived risk, attitudes and behaviors
of men concerning HPV vaccine uptake and related cancers. Chapter 3 contains the methodology
used to accomplish the purpose of the study. The results of the study will be discussed in Chapter
4. Chapter 5 contains a discussion of the results, conclusions drawn because of the study, and
implications and recommendations for future studies.
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CHAPTER 4
RESULTS
Chapter four presents the results of this study pertaining to the knowledge, attitudes,
subjective norms, perceived behavioral control and intention of receiving the HPV vaccinations
among college aged students. The Theory of Planned Behavior constructs guided the survey
questions and framed the results of the study.
The data will be presented in the following order: Demographic variables that describe
the study sample, and the results of the study will be presented by research questions. Statistical
analysis performed included frequencies, descriptive statistics, one-way analysis of variance
(ANOVA), correlation analysis, cross-tabulation and odds ratios.
Demographic variables
Demographic data collected included questions pertaining to gender, race, major/college
within the university, year in school, self-report of sexual activity, age of first sexual intercourse,
current relationship status and general health status. The majority of the respondents were female 252
(51.2%) and 131 (34.2%) were male. There were 51 respondents (14.6%) who did not respond to the
question of gender. There were 216 (56.4%) who identified as White/Caucasian. The remaining
respondents were broken down as follows: Black or African American, 118 (30.8%), 1 (.3%)
respondent was American Indian or Alaskan Native, 7 (1.8%) respondents were Asian, 1

(.3%) respondent identified as Native Hawaiian or Pacific Islander, 22 (5.7%) identified themselves
as two or more races, and 14 (3.7%) respondents identified as other race. Four respondents did not
report their race. With respect to year in school, the sample was comprised of 82 (21.4%)
Freshmen, 49 (12.8%) Sophomores, 108 (28.2%) Juniors, and 119 (31.1%) Seniors. Table 4.1
presents the demographic variables for this study.
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Table 4.1
Descriptive Statistics of Demographic Variables of the Total Sample of College Students
Variable
Frequency (n) Percentage (%)
Gender
Female
Male

196
131

51.2
34.2

Race
White/Caucasian
Black or African American
American Indian or Alaskan Native
Asian
Native Hawaiian or Pacific Islander
Two or more races
Other

216
118
1
7
1
22
14

56.4
30.8
.3
1.8
.3
5.7
3.7

College
Jiann-Ping Hsu College of Public Health
College of Business Administration
College of Behavioral and Social Sciences
College of Arts and Humanities
Waters College of Health Professions
College of Education
College of Science and Mathematics
Other

77
41
22
62
35
81
12
50

20.1
10.7
5.7
16.2
9.1
21.9
3.1
13.1

Year in School
Freshman
Sophomore
Junior
Senior

82
49
108
119

21.4
12.8
28.2
31.1

Respondents were asked about whether they had ever been sexually active and their age
of first sexual intercourse. For the current sample, 88% reported that they have had sexual
intercourse (anal, oral or vaginal). For both male and female students in the sample, the mean age
at first sexual intercourse was in the 16-18 year age category with responses ranging from age 11 to
23. The mean number of sexual partners was 4.57 for female students (n=196) and 6.9 for male
students (n=131). There were 55 students who did not respond to this question. Most of the
respondents identified as being single, 111 (29.0%); with 66 (17.2%); 15 (3.9%) reported as being in a
monogamous relationship; married and living with a partner and the same number not married but
living with a partner. Only one respondent identified as divorced. Finally, respondents were
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asked to report their general health status. More than half of the respondents reported their general
health to be very good to excellent. It would be expected that most college students in the age
range of this sample would be in good health. There were three responses that were missing for
this variable. Data for these variables are presented in Table 4.2.
Table 4.2
Frequencies for sexual activity, Age at first intercourse, and perception of overall health of the total
sample of college students
_________________________________________________________________________
N
%
Sexually Active
Yes
337
88.0
No
36
9.4
Sexually Active
Females
Yes
No
Males
Yes
No
Age of First Sexual Intercourse
11-12
13-15
16-18
19-22
23+
Health Status
Excellent
Very Good
Good
Fair
Poor
Ever been vaccinated
Females
Yes
No
Male
Yes
No

170
23

88.1
11.0

115
13

89.0
10.2

3
50
190
80
18

.9
14.2
54.0
22.7
.8

72
138
97
56
17

18.8
36.0
25.3
14.6
4.4

115
53

59.0
27.2

37
34

30.0
27.9

Because HPV is primarily a sexually transmitted disease, the researcher was interested in
seeing the relationship between year in school and self-report of ever having been sexually active.
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A cross tabulation was performed for these variables. For the current sample of university
students, those who were sexually active increased with year in school beginning in the sophomore
year. It is interesting to note that in this study, more freshmen respondents reported being sexually
active than sophomores. The results are presented in Table 4.3.

Table 4.3
Crosstabulation for Ever had sex by Year in school
Year in School
No

Have you ever had sex?
Yes

Total

Freshman
Sophomore
Junior
Senior

9
6
10
11

66
43
96
108

75
49
106
119

Total

36

313

349

Participants were asked if they had ever been vaccinated against HPV. There were three
choices of answers: Yes, I have received all three doses of the vaccine, No I either never received any
dosage OR I received partial dosage, and not sure. Answers were coded as one for yes, zero for no or
partial and two for not sure. Comparison of male to female vaccination rates found that females were
1.945 times (1.450, 2.607) more likely to have been vaccinated against HPV than males (received all
three doses) (see Table 4.4). This is a significant finding (p<0.005).

Table 4.4
Odds Ratio Comparing Female to Male Vaccination Rates
____________________________________________________________________________
Variable
N
OR
95% CI
Chi Square
____________________________________________________________________________
Vaccinated 317
1.945*
1.450, 2.607
24.67

The remaining results will be reported by the research questions. Questions 2-4 in
this study were formulated around the constructs of the Theory of Planned Behavior.
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Research Question 1
Is there a difference in knowledge about HPV between male and female college students? Prior
to the analysis of variables that align with the constructs of the Theory of Planned
Behavior, a set of 10 questions (7 multiple response and 3 single response items) assessing the level
of knowledge about HPV and the HPV vaccine were performed. For the single response questions,
there was only one correct answer. Responses were coded as “0” for incorrect and “1”

for correct. For the multiple response questions, each response was coded separately. A crosstabulation of knowledge questions by gender was run to compare percentages by demographic
characteristics. The results are presented in Table 4.5
Table 4.5
Crosstabulation of knowledge questions by gender
Variables
Agree
Disagree
Males
Males
%
If you have ever heard of
HPV, the symptoms of
HPV include:
Warts that sometimes itch or
bleed
Sores of the penis or vagina
that don’t heal
Discharge from genitals
Warty growths
Burning upon urination
Reduction of urine flow
No visible signs or
symptoms
Don’t know
If untreated, HPV can
Cervical cancer
Infertility
Pre-cancer
Death
Cause warts
Will disappear
Don’t know
How do you think HPV is
spread?
Vaginal sex

Agree
Females

n %

n

68.0

89 32.0

42

60.3

139 29.7

57

53.4

70 46.6

61

55.6

109 44.4

87

50.3
54.1
50.4
46.6

66
71
66
61

65
60
65
70

45.9
54.6
50.0
50.5

106 54.1
107 45.4
98
99 44.4

90
89

7.6

10 92.4 121 8.1

49.7
45.9
49.6
54.4

%

Disagree
Females
n

%

Don’t
know

n %

12.2
21.4
9.2
27.5
10.7
29.9

16
28
12
36
14
26

75.5
69.4
75.0
62.8
75.0
71.4

84

16 91.9 180

148
136
147
123
147
140

24.5
30.6
25.0
37.2
25.0
28.6

9.1

12 88.8

174 11.2

4

48
60
49
72
49
56

P<0.05

4.8

90.8 119

n

P<0.05

1.1
87.8 115
78.6 103
90.8 119
72.5 95
89.3 117
80.1 105

P value

22

36

P<0.05
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Anal sex
Oral sex
Don’t know
Ways to help prevent the
spread of HPV
Abstinence
Proper condom use
Don’t know
Which of the following
increases your risk for
HPV infection
Sex before the age of 18
You have many sexual
partners
Your partner has many
sexual partners
Excessive stress
Poor nutrition
Smoking
Don’t know
Have you ever heard of
GardasilTM, a vaccine to
prevent cervical cancer
that was approved by the
FDA in June 2006?
Yes
No
Not sure

90.0 118
70.2 92

10.0
29.8

13 88.2
39 69.3

173
136

11.8
10.7

23
60
5.1

71.8 94
85.5 112

28.2 37
14.5 19

77.6
82.7

152
162

22.4
17.3

44
34

P<0.05
7.8

77.0 101

23.0

30 73.0

143 27.0

53

86.0 113

13.0

12

85.0

166 15.0

30

88.5 116
44.0 58
32.0 43
15.0 20

11.5 15
56.0 73
68.0 88
85.0 111

82.7
50.0
38.8
20.0

162
98
76
39

34.0
68.2

45 70.0
25 65.0

138
127

29

P<0.05

17.3 34
50.0 98
61.2 120
80.0 157
6.4

66.0 86
30.0 90

19

24

30.0 58
35.0 67

P<0.05
17.4

65

The results show that 85.6% female respondents and 83.2% male respondents had heard
of HPV. There were 70% of the female respondents and only 66% of the male respondents that had
heard about the HPV vaccination. When asked if they believed that warts that sometimes itch or
bleed are a symptom of HPV, 68% of the male respondents agreed and only 60.3% of the female
respondents agreed. However, when asked if abstinence was a way to prevent the spread of HPV,
77.6% of the female respondents agreed and only 70.1% of the male respondents agreed.
Mean knowledge scores were also calculated by gender and an independent t-test was
run to determine if there was a statistically significant difference between genders on the
knowledge score. The results are presented in Table 4.6.
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Table 4.6
Mean averages of HPV knowledge question responses by gender - test of significance by gender
_______________________________________________________________________________
Variable
M
SD
t
df
p
_______________________________________________________________________________
Knowledge about
0.577
316
.564
HPV vaccination
Males
47.1679 13.78525
Females
48.1230 15.01615
______________________________________________________________________________

Table 4.6 shows that there was no statistical difference between male and female students
on their knowledge about HPV (p = .564). Closer inspection of the two group’s means indicates
that the male students (x̅ =47.1679) scored lower than the female students on their knowledge of
HPV (x̅ = 48.1230). Results indicate that knowledge about HPV was low for both male and female
university students. This is especially troubling as HPV is the main risk factor for reproductive
organ cancers in both men and women.
In comparison to the female respondents, the knowledge deficit for males was slightly
higher regarding the importance of both genders receiving the vaccination. The results of the study
indicate that both males and females had little or no knowledge about the male role in the spread of
HPV infections (see Table 4. 13).
Research Question 2
Is there a difference in attitude between males and females toward obtaining the HPV vaccine?
The second construct of the Theory of Planned Behavior examines how attitudes/beliefs
influence behavior. In the current study, how attitudes/beliefs about HPV and the HPV vaccine
were examined. Respondents were asked 12 Likert-scale questions, coded as 5 for strongly agree,
4 as agree, 3 as not sure, 2 as disagree and 1 as strongly disagree. A mean score closer to five
would indicate positive attitudes/beliefs about the HPV vaccine as protection against the virus
and/or subsequent development of cancer. Table 4.7 reports the mean scores on attitudes and
beliefs by gender.

48
Table 4.7
Mean Scores and Standard Deviation on Attitudes toward obtaining the HPV vaccine
___________________________________________________________________________
Males
Females
Variable
M SD
M SD
___________________________________________________________________________

HPV shot not safe
HPV vaccines give one the disease
HPV shot protects males’ health
Vaccine protects against oral cancer
Vaccine protects against anal cancer
Vaccine protects against genital warts
Vaccine protects sexual partners
Asking for vaccine would be embarrassing
Getting infected with HPV concerns me
Worried about HPV causing cancer
Worry about spreading to someone
HPV responsibility of women

2.68
2.71
3.51
3.01
2.96
3.17
3.47
2.54
3.13
3.58
2.97
2.53

1.069
1.078
1.098
.916
.854
.876
1.077
1.307
1.234
1.243
1.559
1.338

2.02
2.35
3.87
2.87
2.93
3.04
3.53
1.88
3.44
3.44
2.46
2.04

1.076
1.057
1.022
.770
.832
.890
1.057
1.075
1.326
1.326
1.454
1.183

For the attitudes and beliefs about HPV mean scores ranged from x̅ =2.54-3.58 for males
and x̅=2.02-3.53. The lowest mean score for males was x̅= 2.53 for the statement “HPV is the
responsibility of women” indicating that male students were not sure that this should be true. For

the female students the lowest mean score was x̅=1.88 was for the statement “Asking for vaccine
would be embarrassing,” indicating their disagreement that they would be embarrassed to ask for
the vaccine. The mean scores for the set of questions assessing attitude/beliefs about obtaining the
HPV vaccine indicated very unsure attitudes/beliefs for both males and females about the
protectiveness of the HPV vaccine to prevent HPV infection and cancer development. An
independent t-test was run to determine if statistically significant gender differences existed for
mean scores on attitudes/beliefs about obtaining the HPV vaccine. Table 4.8 shows that male
students differed significantly from female students on their attitudes/beliefs about obtaining the
HPV vaccination (p = .000), indicating the males have a more negative attitude toward obtaining
the vaccination.

49
Table 4.8
Means Scores and Standard Deviation of attitude responses concerning HPV vaccination
by gender-test of significance by gender
_______________________________________________________________________________
Variable
M
SD
t
df
p
_______________________________________________________________________________
Attitude about
4.681
308
.000*
HPV vaccination
Males
3.1880
.51304
Females
3.4505
.46384
______________________________________________________________________________

Research Question 3
Is there a difference in the influence of others between males and females toward obtaining
the HPV vaccine?
The influence of others, the subjective norms construct of the Theory of Planned
Behavior, examines how important people in a person’s environment may influence decisions
about behavior (the world around them, friends, family, peer group behavior), specific to this study,
the decision to obtain the HPV vaccine. This construct was assessed by five questions from a fivepoint Likert scale. Responses were coded as 5 for strongly agree, 4 as agree, 3 as not sure, 2 as
disagree and 1 as strongly disagree. A mean score closer to 5 would indicate that the individual
would be more likely to be influenced by subjective norms in their decision to receive the HPV
vaccination. Mean scores for each item were calculated for both male and females and are
presented in Table 4.9.
Means scores for all items in this subscale yielded mixed results. Mean scores ranged
from x̅ = 2.66-3.41 for males and x̅ =2.36-4.05 for females, closer to being influenced by
people rather than social pressure; with female students agreeing that their doctor would
support them getting the vaccine.

Table 4.9
Means Scores and Standard Deviation of Influence of others as a barrier to HPV vaccination
by gender
Males
Females
Variable

M

SD

M

SD

___________________________________________________________________________

50

Important people want shot for me
It is expected that I get shot
I am under social pressure to get shot
My doctor would support getting shot
People like me are getting shot

3.14 1.043
3.13 1.119
2.66 1.161
3.41 1.159
2.98 0.818

3.54
3.51
2.36
4.05
3.46

1.127
1.164
1.115
1.054
1.016

The mean scores for female students were higher than for male students on all response
items on this subscale, except for the item “I am under social pressure to get the shot”. A test of the
overall means for the scale found a significant difference between male and female students on
their influences toward receiving the HPV vaccination (p =0.000). This suggests that males were
less likely to be influenced by people close to them compared to females to obtain the HPV
vaccination. The results are presented in Table 4.10.
Table 4.10
Means Scores and Standard Deviation of the influence of others in obtaining the HPV vaccination
test of significance by gender
_______________________________________________________________________________
Variable
M
SD
t
df
p
_______________________________________________________________________________
Influence toward
3.798
323
0.000*
HPV vaccination
Males
3.0615
.66068
Females
3.3856
.75614
______________________________________________________________________________
*p<0.05
Research question 4
Is there a difference between males and females on their perceived behavioral control to
obtain the HPV vaccine?
In the Theory of Planned Behavior attitude toward behavior, subjective norms, and
perceived behavioral control, shape an individual's behavioral intentions that lead to a behavior.
The final construct that was assessed prior to examining overall intention to obtain the HPV
vaccine, was Perceived Behavioral Control. Perceived behavioral control measured a person’s
belief in their ability to be successful and perform a behavior.
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For this study, the construct Perceived Behavioral Control was measured by four items:
“Can get shot if want to”; “Confident that I can get shot”; “Vaccination beyond my control”;
“Getting shot is up to me”; and “It would be easy to get shot”. The mean scores for these items are
presented in Table 4.11.
Table 4.11
Mean scores and Standard Deviation on Perceived Behavioral Control to receive the HPV vaccine
Males
Females
Variable
M
SD
M
SD
___________________________________________________________________________
Can get shot if want to
Confident that I can get shot
Vaccination beyond my control
Getting shot is up to me
It would be easy to get shot

3.62
3.56
2.50
3.55
3.55

1.255
1.216
1.218
1.377
.854

4.29 .947
4.29 .958
1.95 1.049
4.17 1.039
4.28 .950

Table 4.12 shows that male students (x̅=3.04) were significantly different from female students
(x̅=3.8) on their overall perception of behavioral control for obtaining the HPV vaccine (p=0.000).
Inspection of the two groups indicates that perceived behavioral control is a strong indicator of
whether an individual will be vaccinated or not.

Table 4.12
Mean scores of perceived behavioral control responses concerning HPV vaccination by gendertest of significance by gender
_______________________________________________________________________________
Variable
M
SD
t
df
p
_______________________________________________________________________________
Perceived Behavioral Control
5.712
324
0.000*
HPV vaccination
Males
3.3557
.81043
Perceived Behavioral Control
HPV vaccination
Females
3.7938

5.712

324

0.000*

.57433

____________________________________________________________________________
*p<0.05
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The final analysis performed was a binomial logistic regression to create a prediction
model that included the knowledge, attitude/beliefs, influences on behavior (subjective norms) and
perceived behavioral control on intention to receive the HPV vaccine. The question “The
information you have about the vaccine has caused you to” was recoded from 6 responses to 2
where the first response “be vaccinated” was the reference. The analysis for logistic regression did
not differentiate between participants who were not vaccinated and those who had received at least
one shot in the series. The results of the logistic regression are presented in Table 4.13.
Research Question 5
Is there a difference between males and females in intention to obtain the HPV vaccine?
Table 4.13
Summary of Logistic Regression Analysis for Variables Predicting Decisions to Vaccinate Against
HPV
________________________________________________________________________
Predictor
Female

B
Attitude
Influences
Perceived behavioral control

1.775
5.492
3.127

SEB
0.183
0.003
0.010

ß
1.040
1.356*
2.834

Male
Attitude
2.101
0.147
1.059
Influences
3.063
0.070
2.119
Perceived Behavioral Control
2.205
0.007
1.930*
_____________________________________________________________________________
Note. R2 = .52: F(186,131) = 12.23
*p<0.05 **p<0.01 ***p<0.001
The logistic regression was performed to ascertain the effects of gender, attitudes,
influences, and perceived behavioral control on the likelihood that participants intend to obtain the
HPV vaccine. The analysis did not differentiate whether participants had been vaccinated or not.
The logistic regression model was statistically significant for the construct scores of perceived
behavioral control and influences on intention to obtain the HPV vaccine. The results found that
females in the study had a 2.834 times higher perception of their ability to obtain the HPV
vaccination compared to the males (1.930). For social norms influence on obtaining the HPV
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vaccine, male respondents were 2.119 times more likely to be influenced by family or friends
compared to female respondents, suggesting that the males believe that people who are
important to them would want them to receive the vaccination.
Logistic regression determines the likelihood value or predicted probability of getting a
desired result, therefore, the data suggests that attitudes were not a strong predictor for HPV
vaccination among the participants. However, the data does suggest that gender, perceived
behavioral control and influence of others were predictors for the participants’ intentions to
receive the HPV vaccination. These findings are consistent with the overall means scores for
perceived behavioral control in that male participants (x̅=3.04) scored significantly lower than
female participants (x̅=3.8) in the study.
Summary
The results of the study were presented in this chapter. Overall results indicate that males
are less knowledgeable than females on specific facts about the HPV virus and the vaccination.
Both male and female students had little knowledge about the role of males in the spread of HPV.
Embarrassment about asking a physician about the vaccination was listed as a factor in obtaining
the vaccination for both males and females. Male participants scored significantly lower than the
score for female participants when asked if they are influenced by family or peers to receive the
HPV vaccination, indicating that males are not being influenced by significant others to get
vaccinated. Finally, the results show that male students were significantly different from female
students on their overall perception of behavioral control for obtaining the HPV vaccine.
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CHAPTER 5
DISCUSSION
The purpose of this study was to assess the attitudes toward the HPV vaccination and its
influence to serve as a barrier to HPV vaccine acquisition among a sample of rural university
students. Specifically, this study investigated whether knowledge about HPV, attitude toward
HPV, the influence of others, and perceived behavioral control predicted the intention to receive
HPV vaccination and whether the pattern of these influences differed by gender. The subjects for
the study were 383 matriculated students, enrolled at a university in Southeast Georgia. This
chapter contains the summary and discussion of the quantitative results as they relate to existing
literature, the conclusions of the study, the limitations of the study, implications for communitybased public health practice and recommendations for future study on how HPV vaccination
uptake is influenced.
Summary and Discussion
The current study utilized the Theory of Planned Behavior as a framework for data
analysis and understanding of college aged students’ knowledge, attitudes, influences of others, and
perceived behavioral control about HPV, and the intention to be vaccinated to prevent
HPV. Overall, males were less knowledgeable about HPV including risk factors, treatment, and
prevention compared to females. This is similar to results found in a study by Stanley (2017) in
which it was found that while most of the men in the study envisioned an ideology that men and
women share equal knowledge about sexual health, realistically, most of the men agreed that
women have better access to knowledge about sexual health through their mothers . The study also
found that men believed that their fathers felt too much discomfort to discuss sensitive sexual
material with their sons. Because there is a discrepancy in the parental knowledge afforded to sons
and daughters about sexual health, there is a significant knowledge deficit for males concerning
HPV risk factors, treatment, and prevention (Stanley, 2017).
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The results of the study indicate that a higher percentage of males had also not heard
of Gardasil. One reason that might explain this is that advertisements and recommendations
from health care providers were until recently were targeted towards young women. This result
is consistent with another study in which respondents were asked about Gardasil (Gilbert, 2010).
Even before the HPV vaccination Gardasil was approved, Merck Pharmaceuticals touted the
vaccine as a women’s only health issue through their awareness campaigns that linked the
vaccine’s effectiveness in decreasing incidence of cervical cancer, though research has proven a
positive link in the transmission of HPV to both men and women.
The study demonstrated that male and female university students have different
perceptions about the role they play in acquiring HPV and preventing the spread. More female than
male students strongly agreed that HPV prevention should be the responsibility of women. The
results of the current study are similar to findings from a study performed by Ott (2010) in which it
was posited that the cultural norms and attitudes toward males’ perception of sexual health can
stem from interpersonal relationships. Cultural views of masculinity and gender roles about sexual
health are well defined by the time men enter college (Ott, 2010). In another study, it was
hypothesized that most of the male participants in the study would report that they had not heard of
Gardasil as a vaccination for the prevention of HPV and related cancers for men. As expected,
most of the male participants indicated that they were unaware of the male role in the spread of
HPV and were unaware of a vaccination for the prevention of HPV (Gilbert, 2010). In the study
performed by Catalano (2017), insufficient knowledge about HPV was directly correlated with low
vaccination rates among males (Catalano, et.al, 2017).
Attitudes/Beliefs toward HPV and HPV vaccine
Overall, attitudes and beliefs about HPV and obtaining the vaccine among the males in the
study showed that they had more negative attitudes and beliefs about HPV vaccination uptake.
Because the Theory of Planned behavior posits that the key component to the model is behavioral
intent in that behavioral intentions are influenced by the attitude about the likelihood that the
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behavior will have the expected outcome, this finding is significant in determining why male
vaccination rates for HPV are low (Thompson, et.al., 2016).
The current study suggests that attitudes toward HPV vaccination and the ability to
perform them were strong predictors of whether male students would be vaccinated. The findings
are consistent with a study performed by Gilbert (2010) in which the contextual development
about sexual issues for males, as well as sexual health, were studied in familial and institutional
environments to gain a better understanding about their relationship to HPV vaccine uptake among
males (Gilbert, 2010). Gilbert’s study suggested that perception of the “feminization” of sexual
issues dictates the male role in responsibility toward sexual health and prevention measures,
including HPV vaccine uptake.
The Theory of Planned Behavior also asserts that subjective norms, or what an
individual is exposed to socially or familiarly, has a considerable impact on his or her intention to
perform a behavior. The mean scores for female students were higher than for male students on all
response items about the influence of others to receive the HPV vaccine except for the item “I am
under social pressure to get the shot.” This is consistent with a study by Stanley which asserts that
because men have consistently not been the target of ad campaigns for HPV prevention, perceived
norms for male vaccination may not be established yet (Stanley, 2017).
Perceived Behavioral Control
Perceived Behavior Control, or the belief that an individual can perform a certain
behavior, was a weak predictor of intention to obtain the vaccine. Because the data in the current
study is consistent with results in the study by Catalano, et.al., (2017) finding that perceived
behavioral control adds only slightly to the overall predictive power of the TPB and HPV
vaccination, suggesting that attitudes, knowledge, and influence may be more important predictors
for HPV vaccination. In the study by Catalano et.al., (2017) it was suggested that because
respondents lacked enough knowledge about HPV and the HPV vaccination process, they would
not be able to make an adequate assessment about what the vaccination process would entail
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(Catalano, et. al., 2017). Inadequate knowledge about HPV and HPV vaccination was also a
factor in low means scores for behavioral intention to receive the HPV vaccination for both male
and female respondents in the current study.
Because the initial approach by Merck Pharmaceuticals for the HPV vaccination was
focused on attaining higher vaccination rates among females, males have been at a disadvantage in
gaining the knowledge and awareness necessary to achieve perceived ability to receive the HPV
vaccination within the context of perceived barriers.
Intention to Obtain the HPV Vaccination
Although most men had heard of HPV, they knew relatively little about the HPV
vaccination, the risks for infection, and their role in the spread of HPV. The results are consistent
with the study by Johnson and Ogletree (2017) in that perceived knowledge about HPV vaccination
may be part of the males’ belief systems, which would motivate them in their intention to receive
the vaccination. The females in the in the study scored slightly higher for both knowledge about
HPV and the HPV vaccination. However, because the HPV vaccine was initially approved for and
marketed to women by Merck Pharmaceuticals, it is not surprising that the females in the study
knew more about it than the males did.
Among the female respondents who had not received the vaccine (N= 79), most of them
reported greater perceived behavioral control in their intention to one day be vaccinated. Although
most of the men believed that they could get the vaccination if they wanted to, the majority of the
males in the study indicated that they had not heard of Gardasil prior to the current study,
suggesting that there are still significant gaps in the marketing of Gardasil for men that need to be
addressed. These findings are similar to the study by Catatlano, et. al., (2017), in that most of the
males in their study had heard HPV but 60% of the respondents indicated that they had not heard of
HPV vaccinations for men. (Catalano, 2017)
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Limitations
Limitations were taken into consideration when presenting the findings from the study.
Attempts were made to recruit a diverse sample by using random sampling. Since the instrument
was administered as a self-reported questionnaire, information collected may not be accurate.
The questions in the survey may have been a limitation in that they have predetermined response
categories, thus limiting the range of responses. Because the HPV vaccine has been approved for
young men and women ages 9 to 26, another limitation of the study could be that only college
students ages 18 to 26 are being examined. Efficacy of vaccine uptake in future trials should be
performed with a larger cohort, with a more diverse age group in the sample.
The sample size for qualitative studies was small and the findings necessary for this indepth exploratory research study was limited and may have confounded the data because
qualitative research tends to have less statistical power than quantitative research when it comes to
verifying trends. Although the quantitative analysis minimized confounding, a quantitative
approach for research analysis is limited in providing an adequate explanation for social or cultural
phenomena. The utilization of a mixed-method study may have potentially counterbalanced the
weaknesses of the study, however time constraints were a factor as well, because data was only
collected in classes during times that were approved by the instructor.
Recommendations for Future Studies
Because HPV is commonly thought of as a women’s health issue, males are at a
disadvantage concerning accurate information given to them about HPV and HPV vaccinations
from peers, family members and the media. A multi-level approach, such as utilizing the Social
Ecological Model (SEM), can assist researchers in determining the personal and environmental
factors that influence behaviors; in this case, what factors determine whether males will be
vaccinated against HPV or not. At the individual level, researchers can look at male participants’
level of education, socioeconomic status, or their lack of knowledge about the HPV vaccination
program. At the interpersonal level, parental and peer influence toward HPV vaccination can be
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assessed, as well as cultural or religious influences about sexual issues. The organizational, community
and policy levels of the SEM can be studied by researching the lack of communication and education
concerning HPV vaccination in neighborhoods, schools and workplaces.

The lack of dissemination of information about the importance of receiving the HPV
vaccine from healthcare providers to male patients is wholly under-researched. Interventions to
stress the importance of healthcare providers acknowledging the HPV vaccination as genderless
is imperative to increase male vaccine uptake.
To achieve more in-depth and robust findings, future studies should employ a mixed
methods approach. Because research about barriers to male HPV vaccination is wholly underresearched, adding a qualitative piece would allow researchers gains in breadth and depth of an
understanding of this phenomenon, while offsetting the weaknesses inherent to using a
quantitative approach by itself.
To get a more definitive result from logistic regression analysis for perceived
behavioral control, future researchers should differentiate between participants who have never
received the HPV vaccination and those who have had at least one shot in the series.
Implications for Public Health Practice
The current findings have several important implications for public health education to
promote HPV vaccine uptake and the prevention of HPV-related cancers among men and women.
It appears that knowledge about HPV and HPV prevention is a strong predictor of HPV vaccination
among males. This finding provides opportunities for public health programs in that they can be
designed specifically to increase knowledge and awareness among males about HPV acquisition
and their role in the spread of the disease. A partnership could be formed with the university and
local health departments to implement HPV and HPV vaccination programs; particularly among
male students.
Strong familial and social support for HPV vaccination influence both females’ and
males’ intention for HPV vaccination in the current study. To increase vaccination rates among
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males, it is imperative that ad campaigns continue to target parents of adolescents. Based on the
findings from this study, it is clear that public health programs are necessary to educate men about
the importance of receiving the HPV vaccination and the efficaciousness of the HPV vaccination.
Without HPV vaccination programs to educate males about the severity of HPV related cancers
specific to men, rates for male vaccination uptake continue to be significantly lower than those for
women.
Because it was concluded from this study that social norms (family and friends) from
specific sources is a strong indicator for men’s intentions to receive the HPV vaccination,
public health educators can develop programs that prioritize broad social support to enhance
male vaccination uptake, including forming social support networks consisting of physicians,
family, friends and peers.
The economic burden associated with non-cervical HPV-related cancers occurring in
individuals living in the United States was approximately $418 million in 2014. It would be
financially advantageous for the United States to implement programs promoting the use of 9vHPV
vaccines to protect males against contracting oncogenic HPV types to decrease morbidity and
mortality rates due to HPV related cancers. Practitioners, universities and Health Departments can
provide basic information about HPV to the public that includes information about the route of
transmission, prevalence of HPV-related cancers among men and women and the safety and
efficaciousness of the vaccine as protection against HPV acquisition.
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APPENDIX A
KNOWLEDGE AND ATTITUDES TOWARD THE HUMAN
PAPILLOMAVIRUS (HPV) VACCINE AMONG COLLEGE STUDENTS
My name is Kristina Harbaugh and I am a doctoral student at Georgia Southern University Jiann-Ping
Hsu College of Public Health. You are invited to participate in a research study that is assessing the
knowledge about and attitudes toward the Human Papillomavirus (HPV) vaccine. Results from the
study will be used to develop strategies to increase the participation rate among males in obtaining
the HPV vaccine as a cancer prevention measure. Please DO NOT write your name or any other
identifying information anywhere on the questionnaire. Responses will be kept confidential and will
only be seen by myself and the dissertation committee. Your participation is voluntary. Completing
the survey in its entirety indicates consent to participate. You may choose to withdraw from
completing the survey or to not answer a specific question. Thank you for your help in learning more
about the knowledge, attitudes and intention to obtain HPV vaccine. This project has been reviewed
and approved by the GSU Institutional Review Board under tracking number H18352. For questions
concerning your rights as a research participant, contact Georgia Southern University Office of
Research Services and Sponsored Programs at 912-478-5465.

Section I: In this section, you are being asked about your knowledge about the
Human Papillomavirus (HPV). Please check all that apply

1. From which of the following sources, have you ever heard about HPV? (Please check all that
apply)
________Doctor
________Friends/Acquaintances
________Health education program (i.e. at school or business)
________Magazine, newspaper, or another periodical
________Radio or TV
________Have never heard of HPV (Human papillomavirus) until today
2. If you have ever heard of HPV, the symptoms of HPV include: (Please check all that apply)
_______Warts that sometime itch or bleed
_______Sores of penis or vagina that don’t heal.
_______Discharge from genitals (watery, yellow, white discharge)
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_______Warty growths
_______Burning upon urination
_______Reduction of urine flow
_______No visible signs or symptoms
_______Don’t know
3. If untreated, HPV can: (Please check all that apply).
_______Cause cervical cancer _______Can cause warts _______Cause
infertility _______Will usually disappear by itself _______Can cause precancer _______Can cause sterility _______Can cause death
________Don’t know
4. How do you think HPV is spread? (Please check all that apply).
_______Vaginal sex
_______Kissing
_______Anal sex
_______Coughing
_______Oral sex
_______Toilet seat
_______Casual contact (Hug, handshake) _______Don’t know
5. HPV is more likely to be spread by the: (Please check one).
_______Male
_______Female
_______Male or female
_______Don’t know
6. HPV can be passed from the mother to her baby during birth (Please check one answer).
_______True
_______False
_______Don’t know
7. Ways to help prevent the spread of HPV are: (Please check all that apply).
_______Abstinence
_______Douching
_______Proper condom usage
_______Withdrawal of penis before ejaculation
_______Washing after sex
_______Don’t know
8. Which of the following increases your risk for HPV infection (Please check all that apply).
_______Sex before the age of sixteen
_______Birth control pills
_______You have many sexual partners
_______Smoking
_______Your partner has had many sexual partners
_______Excessive stress
_______Poor nutrition
_______Don’t know
9. HPV is mainly a disease of (Please check one).
_______Male homosexuals
_______Females
_______Female homosexuals
_______Males
_______Bisexual individuals
_______Anyone having sexual contact
_______Heterosexuals
_______Don’t know
10. Have you ever heard of Gardasil™, a vaccine to prevent cervical cancer that was approved by
the FDA in June 2006? (Please check one).
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_______Yes
_______No
_______Not Sure
11. Have you ever been vaccinated against HPV?
_______Yes, I received all three dosages of the vaccine
_______No, I either never received any dosage OR I received partial dosage (1 of 3 or 2 of 3)
_______Not Sure
For Sections II through IV, choose the level of agreement that best matches your
beliefs, attitudes, or opinion
Section II: The following questions assess your attitude & beliefs toward the HPV vaccine.
Select ONE answer for each item below:
Strongly
Agree
12. It is not
safe to get
the HPV
vaccine
shots.
13. You can
get infected
with HPV
from HPV
vaccine
shots.
14. Getting
vaccine shots
against HPV
would be a
good way for
males to
protect their
health.
15. The
vaccine
would
protect me
against oral
cancer.
16. The HPV
vaccine
would
protect me
against anal
cancer.
17. The HPV
vaccine

Agree

Not
Sure

Disagree

Strongly
Disagree
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would
protect me
against
genital warts.
18. Getting
the HPV
vaccine
would
protect
sexual
partner(s)
against HPV
infection.
19. Asking
for the HPV
vaccine
would be
embarrassing
for me.
20. The
possibility of
getting
infected with
HPV
concerns
me.
21. I would
be more
worried
about
contracting
or spreading
HPV if it
could cause
cancer.
22. If I had
HPV I would
worry about
spreading it
to my partner
only if my
partner is
someone I
really care
about.
23. HPV
prevention
should be the
responsibility
of women
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Section III: The following questions assess the degree to which I value other people’s
opinions concerning the HPV vaccination. Select ONE answer for each item below:
Strongly
Agree
24. Most
people
who are
important
to me
think that
I should
get
vaccinated
against
HPV.
25. It is
expected
of me that
I get
vaccinated
against
HPV.
26. I am
under
social
pressure
to get
vaccinated
against
HPV.
27. My
doctor
would
support
my
getting
vaccinated
against
HPV.
28. Most
people
like me
are getting
vaccinated
against
HPV.

Agree

Not
Sure

Disagree

Strongly
Disagree
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Section IV: The following questions assess the degree to which you would intend to obtain the
HPV vaccination. Select ONE answer for each item below:
Strongly
Agree

Agree

Not
Sure

Disagree

Strongly
Disagree

29. If I
want to, I
can get
vaccinated
against
HPV.
30. I am
confident
that I can
get
vaccinated
against
HPV.
31. Getting
vaccinated
against
HPV is
beyond my
control.
32.
Whether I
get
vaccinated
against
HPV is
entirely up
to me.
33. I
believe
that it
would be
easy for
me to get
the HPV
vaccination
if I wanted
to.
Section V: Please select all that apply.
34. From which of the following sources have you ever received information about Gardasil™?
(Check all that apply)
_______”One Less” Commercial
_______Talk Show
_______News Show
_______Magazine Advertisements
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_______Merck Website
_______General Practitioner
_______University Health Services
_______Family
_______Other
35. If you have not received the vaccine, what influenced you to not get vaccinated? (Check all
that apply)
_______Religious beliefs
_______Safety concerns
_______Cost
_______Do not think it is important
_______Do not think you are at risk
_______Need more information
_______Do not believe in vaccinations
_______Other___________________
_______Not Applicable
36. If the HPV vaccine was offered for free, would you get it?
_______Yes
_______No
_______Not Sure
37. The information you have about the vaccine has caused you to: (Check all that apply)
_______Be vaccinated
_______Speak to your physician or other health professional about the vaccine
_______Share your knowledge with family or friends
_______Do further research on your own about the vaccine and the link
between cervical cancer and HPV
_______Visit Merck’s website
_______I have no information about the vaccine
38. How likely are you to recommend others receive the vaccine?
_______Very likely
_______Somewhat likely
_______Somewhat unlikely
_______Not likely
_______Don’t know/not sure
Section VI: Background Information
This set of questions tells us a little more about who is completing the questionnaire.
Please check only one answer for each question.
39. What is your gender?
________Male
________Female
40. What is your race?
________ White/Caucasian
________ Black or African American
________ American Indian or Alaska Native
________ Asian
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________ Native Hawaiian or Pacific Islander
________ Two or more races
________ Other
41. In which college are you enrolled?
_______Jiann-Ping Hsu College of Public Health (COPH)
_______College of Business Administration (COBA)
_______College of Behavioral and Social Sciences (CBSS)
_______College of Arts and Humanities (CAH)
_______Don & Cindy Waters College of Health Professions (DCWCHP)
_______College of Education (COE)
_______College of Science and Mathematics (COSM)
_______Other________________
42. What is your year in school?
_______Freshman
_______Sophomore
_______Junior
_______Senior
43. Have you ever had sexual intercourse (anal, oral, vaginal)?
________ Yes
________ No
44. Please mark the category that includes the age at which you first had sexual intercourse.
________ (11-12)
________ (19-22)
________ (13-15)
________ (23+)
________ (16-18)
45. How many sexual partners have you had in your lifetime? ______
46. How often do you wear a condom when you are having sexual intercourse?
________ Every time
________ Most of the time
________ Sometimes
________ Hardly ever
________ Never
47. What is your current relationship status?
________ Single
________ Dating
________ Monogamous relationship
________ Married and living with partner
________ Not married but living with a partner
________ Divorced
48. In general, would you say your health is:
________ Excellent
________ Very Good
________ Good
________ Fair

74
________ Poor
THANK YOU!
In order to gain a more in-depth understanding of attitudes toward both HPV and the vaccine to
prevent long-term health consequences, you are invited to participate in a compensated personal
interview. If you are interested, please contact the principal investigator, Kristina Harbaugh in
the following way: (Email) kh03140@georgiasouthern.edu
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APPENDIX B
FREQUENCY STATISTICS OF KNOWLEDGE, AWARENESS, SYMPTOMS, SPREAD,
RISK AND CAUSES OF HPV AMONG FEMALE COLLEGE STUDENTS
Variables

Frequenc
y (n)

Percentag
e (%)

Heard of
HPV

Symptom
s of HPV

Missin
g

56

Doctor

35

17.9

Friends or
Acquaintance

51

26.0

Health
Education
Program

50

25.5

Magazine,
Newspaper or
other
Periodical

37

18.9

Radio or TV

22

11.2

Haver never
heard of HPV
until today

1

.5

1

76

Warts that
itch or bleed

28

14.3

Sores of penis
or vagina that
do not heal

23

11.7

Discharge
from genitals

17

8.7

Warty
growths

23

11.7

Burning upon
urination

7

3.6

Reduction of
urine flow

1

.5

No visible
signs or
symptoms

9

4.6

Don’t know

88

44.9

Untreated
HPV can
cause

1

Cervical
cancer

26

13.3

Infertility

34

17.3

Pre-cancer

28

14.3

Death

20

10.2

77

Warts

20

10.2

Disappears by
itself

18

9.2

Sterility

1

.5

Don’t know

48

24.5

HPV is
spread by

2

Vaginal sex

32

19.4

Anal sex

38

25.5

Oral sex

48

36.7

Don’t know

72

16.3

HPV
more
likely
spread by

HPV
passed
from

2

Male

1

.5

Female

7

3.6

Male or
female

74

37.8

Don’t know

112

57.1

78

mother to
child
during
birth
True

91

46.4

False

6

3.1

Don’t know

98

50.0

Ways to
prevent
spread of
HPV

10

Abstinence

50

25.5

Proper
condom use

91

46.4

Don’t know

43

21.9

What
increases
risk for
HPV
infection

1

Sex before
age of sixteen

6

3.1

Many sexual
partners

86

43.9

Partner has
many sexual
partners

50

25.5

Excessive
stress

5

2.6

79

Poor nutrition

5

2.6

Birth control
pills

4

2.0

39

19.9

Smoking

Don’t know

HPV
mainly a
disease of

1

Anyone
having sexual
contact

91

46.4

Don’t know

104

53.1

Yes

133

67.9

No

41

20.9

Not sure

20

10.2

Heard of
Gardasil

Ever been
vaccinate
d against
HPV

1

Yes

115

58.7

No

53

27.0

80

Not sure

27

13.8
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APPENDIX C

FREQUENCY STATISTICS OF KNOWLEDGE OF AWARENESS, SYMPTOMS, SPREAD,
RISK AND CAUSES OF HPV AMONG MALE COLLEGE STUDENTS
Variables

Frequency
(n)

Percentage Missing
(%)

Heard of HPV

Symptoms of HPV

26

Doctor

34

26.0

Friends or Acquaintances

33

25.2

Health Education Program

34

26.0

Magazine, Newspaper or other
Periodical

15

11.5

Radio or TV

14

10.7

Haver never heard of HPV until
today

1

.8

1

82

Warts that itch or bleed

10

7.6

Sores of penis or vagina that do not
heal

13

9.9

Discharge from genitals

19

14.5

Warty growths

18

13.7

Burning upon urination

7

5.3

Reduction of urine flow

4

3.1

No visible signs or symptoms

5

3.8

Don’t know

54

41.2

Untreated HPV can cause

1

Cervical cancer

13

9.9

Infertility

21

16.0

Pre-cancer

19

14.5

Death

16

12.2

Warts

11

8.4

83

Disappears by itself

5

3.8

Sterility

1

.8

Don’t know

44

33.6

HPV is spread by

3

Vaginal sex

22

16.8

Anal sex

31

23.7

Oral sex

44

24.4

Don’t know

31

23.7

HPV more likely spread by

1

Male

51

38.9

Female

4

3.1

Male or female

12

9.2

Don’t know

63

48.1

HPV passed from mother to
child during birth

4

True

61

46.6

83

False

4

3.1

Don’t know

62

47.3

Ways to prevent spread of
HPV

12

Abstinence

25

19.1

Proper condom use

53

40.5

Don’t know

38

29.0

What increases risk for HPV
infection

1

Sex before age of sixteen

4

3.1

Many sexual partners

64

48.9

Partner has many sexual partners

26

19.8

Excessive stress

5

3.8

1

.8

Poor nutrition

Birth control pills

Smoking

84

Don’t know

30

22.9

HPV mainly a disease of

1

Anyone having sexual contact

55

42.0

Don’t know

75

57.3

Heard of Gardasil

4

Yes

41

31.3

No

60

45.8

Not sure

26

19.8

Ever been vaccinated against
HPV

9

Yes

37

28.2

No

34

26.0

Not sure

51

38.9
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APPENDIX D
FREQUENCY STATISTICS OF FEMALE COLLEGE STUDENTS’ ATTITUDES AND BELIEFS
TOWARD OBTAINING THE HPV VACCINE
Variable

Frequency
(n)

Percentage Missing
(%)

It is not safe to get the HPV vaccine

0

Strongly
disagree

80

40.8

Disagree

56

28.6

Not sure

43

21.9

Agree

10

5.1

Strongly
agree

7

3.6

You can get infected with HPV from HPV vaccine shots

1

Strongly
disagree

53

27

Disagree

47

24

Not sure

74

37.8

86

Agree

15

7.7

6

3.1

Strongly
agree
Getting vaccine shots against HPV would be a good way
for males to protect their health.

0

Strongly
disagree

61

31.1

Disagree

73

37.2

Not sure

44

22.4

Agree

12

6.1

Strongly
agree

6

3.1

The vaccine would protect me against oral cancer.

2

Strongly
disagree

7

3.6

Disagree

16

8.2

Not sure

124

63.3

Agree

38

19.4

87

Strongly
agree

9

4.6

The HPV vaccine would protect me against anal cancer.

1

Strongly
disagree

11

5.6

Disagree

18

9.2

Not sure

123

62.8

Agree

33

16.8

Strongly
agree

10

5.1

The HPV vaccine would protect me against genital
warts.

2

Strongly
disagree

15

7.7

Disagree

29

14.8

Not sure

104

53.1

Agree

40

20.4

Strongly
agree

6

3.1

88

Getting the HPV vaccine would protect sexual partner(s)
against HPV infection.

1

Strongly
disagree

36

18.4

Disagree

72

36.7

Not sure

53

27.0

Agree

27

13.8

Strongly
agree

7

3.6

Asking for the HPV vaccine would be embarrassing for
me

The possibility of getting infected with HPV concerns
me.

1

Strongly
disagree

91

46.4

Disagree

63

32.1

Not sure

21

10.7

Agree

13

6.6

Strongly
agree

7

3.6

3

89

Strongly
disagree

49

25.0

Disagree

61

31.1

Not sure

31

15.8

Agree

30

15.3

Strongly
agree

22

11.2

I would be more worried about contracting or spreading
HPV if it could cause cancer.

1

Strongly
disagree

13

6.6

Disagree

31

15.8

Not sure

37

18.9

Agree

58

29.6

Strongly
agree

56

28.6

If I had HPV I would worry about spreading it to my
partner only if my partner is someone I really care
about.

1

Strongly
disagree

67

34.2

90

Disagree

54

27.6

Not sure

24

12.2

Agree

18

9.2

Strongly
agree

30

16.3

HPV prevention should be the responsibility of women

1

Strongly
disagree

88

44.9

Disagree

46

23.5

Not sure

35

17.9

Agree

17

8.7

Strongly
agree

9

4.6
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APPENDIX E
FREQUENCY STATISTICS OF MALE COLLEGE STUDENTS’ ATTITUDES AND BELIEFS
TOWARD OBTAINING THE HPV VACCINE
Frequency
(n)

Variable

Percentage Missing
(%)

It is not safe to get the HPV vaccine

0

Strongly
disagree

21

16.0

Disagree

29

22.1

Not sure

62

47.3

Agree

9

6.9

Strongly
agree

10

7.6

You can get infected with HPV from HPV vaccine
shots

0

Strongly
disagree

23

17.6

Disagree

23

17.6

Not sure

62

47.3

Agree

15

11.5

Strongly
agree

8

6.1

Getting vaccine shots against HPV would be a good
way for males to protect their health.

Strongly
disagree

22

16.8

Disagree

51

38.9

Not sure

42

32.1

Agree

4

3.1

Strongly
agree

12

9.2

The vaccine would protect me against oral cancer.

The HPV vaccine would protect me against anal
cancer.

92

0

0

Strongly
disagree

12

9.2

Disagree

10

7.6

Not sure

85

64.9

Agree

15

11.5

Strongly
agree

9

6.9

0

Strongly
disagree

9

6.9

Disagree

9

6.9

Not sure

90

68.7

Agree

14

10.7

Strongly
agree

9

6.9

The HPV vaccine would protect me against genital
warts.

93

2

Strongly
disagree

10

7.6

Disagree

27

20.6

Not sure

72

55.0

Agree

15

11.5

Strongly
agree

5

3.8

Getting the HPV vaccine would protect sexual
partner(s) against HPV infection.

0

Strongly
disagree

27

20.6

Disagree

34

26.0

Not sure

50

38.2

Agree

14

10.7

Strongly
agree

6

4.6

Asking for the HPV vaccine would be embarrassing for
me

94

1

Strongly
disagree

35

26.7

Disagree

37

28.2

Not sure

23

17.6

Agree

23

17.6

Strongly
agree

12

9.2

The possibility of getting infected with HPV concerns
me.

2

Strongly
disagree

20

15.3

Disagree

33

25.2

Not sure

34

26.0

Agree

28

21.4

Strongly
agree

14

10.7

I would be more worried about contracting or
spreading HPV if it could cause cancer.

95

Strongly
disagree

21

16.0

Disagree

19

14.5

Not sure

23

17.6

Agree

31

23.7

Strongly
agree

36

27.5

If I had HPV I would worry about spreading it to my
partner only if my partner is someone I really care
about.

HPV prevention should be the responsibility of women

0

Strongly
disagree

36

27.5

Disagree

20

15.3

Not sure

19

14.5

Agree

24

18.3

Strongly
agree

32

24.4

0

Strongly
disagree

37

28.2

Disagree

33

25.2

Not sure

32

24.4

Agree

12

9.2

Strongly
agree

17

13.0

96

97

APPENDIX F
FREQUENCY STATISTICS OF FEMALE COLLEGE STUDENTS’ INTENTIONS TOWARD HPV
VACCINATION
Variable

Frequency
(n)

Percentage
(%)

If I want to, I can get vaccinated against HPV

Missing

1

Strongly
disagree

4

2.0

Disagree

10

5.1

Not sure

13

6.6

Agree

67

34.2

Strongly agree

101

51.5

I am confident that I can get vaccinated against
HPV

1

Strongly
disagree

5

2.6

Disagree

7

3.6

Not sure

18

9.2

Agree

62

31.6

Strongly agree

103

52.6

Getting vaccinated against HPV is beyond my
control

98

Strongly
disagree

83

42.3

Disagree

62

31.6

Not sure

33

16.8

Agree

11

5.6

Strongly agree

6

3.1

Whether I get vaccinated against HPV is entirely
up to me

1

Strongly
disagree

6

3.1

Disagree

14

7.1

Not sure

13

6.6

Agree

70

35.7

Strongly agree

92

46.9

I believe it would be easy for me to get the HPV
vaccination if I wanted to

1

Strongly
disagree

4

2.0

Disagree

8

4.1

Not sure

20

10.2

Agree

61

31.1

Strongly agree

102

52.0
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